Animal/Tissue Order List




  1 - 1224 / total 1224

View Pricing Information

Order Amimal
Tissue
JCRB No.
Cell Name
Profile
bovine:blastcyst          Top
Ask to JCRB bovine blastcyst JCRB1981 BT-J bovine trophoblastic cell line
bovine:blastcyto          Top
Ask to JCRB bovine blastcyto JCRB1955 BT-F bovine trophoblastic cell line
bovine:cornea          Top
Japan Domestic use only bovine cornea JCRB9129 BCE C/D-1b Bovine corneal endothelial cell line.
bovine:kidney          Top
Japan Domestic use only bovine kidney JCRB0008 CKT-1 useful to assay bovine adenovirus 3
Japan Domestic use only bovine kidney IFO50003 CKT-1 This cell line is useful to produce and assay bovine adinovirus 3 in vitro. (J. Virol., 16, 621 (1975)). CKT-1 is a clone of CKT.
Japan Domestic use only bovine kidney JCRB9028 MDBK (NBL-1) established from normal kidney
Japan Domestic use only bovine kidney JCRB0716 MDBK.P3 normal kidney, MDBK derivative, no serum required
bovine:lung          Top
Japan Domestic use only bovine lung JCRB9038 EBTr (NBL-4) embryonic trachea
bovine:trophoblast          Top
Ask to JCRB bovine trophoblast JCRB1927 BT-A bovine trophoblastic cell line
Ask to JCRB bovine trophoblast JCRB1935 BT-B bovine trophoblastic cell line
Ask to JCRB bovine trophoblast JCRB1936 BT-D bovine trophoblastic cell line
bovine:vascular system          Top
Japan Domestic use only bovine vascular system JCRB9025 CPA pulmonary artery normal endothelial cell
Japan Domestic use only bovine vascular system JCRB9022 CPAE pulmonary artery normal endothelial cell
Japan Domestic use only bovine vascular system IFO50154 FBHE Normal diploid endothelial cells with limited life span. FGF-dependent for survival.
Japan Domestic use only bovine vascular system JCRB0099 HH carotid artery normal endothelial cell
Japan Domestic use only bovine vascular system JCRB0155 NM-1 Newly established primary bovine cell line established from artery which is confirmed to be free from BVDV contamination.
cat:kidney          Top
cat kidney JCRB9035 CRFK kidney, BVD antigen negative
cat:neural          Top
cat neural JCRB9125 PG-4(S+L-) brain derived cell line transformed with Moloney murine sarcoma virus, support type C retroviruses
chicken:hemo-lymphocytic          Top
Japan Domestic use only chicken hemo-lymphocytic JCRB9130 DT40 avian leukosis virus (ALV)-induced lymphomas
chicken:liver          Top
Japan Domestic use only chicken liver JCRB0237 LMH hepatocelluler carcinoma, diethylnitrosamine induced
chimpanzee:hemo-lymphocytic          Top
Japan Domestic use only chimpanzee hemo-lymphocytic JCRB1165 HSP-239 Peripheral blood lymphocyte cell line of chimpanzee.
Japan Domestic use only chimpanzee hemo-lymphocytic JCRB1177 HSP-250 Peripheral blood lymphocyte cell line of chimpanzee.
dog:kidney          Top
dog kidney JCRB9029 MDCK (NBL-2) established from normal kidney, susceptible for many viral species
dog kidney IFO50071 MDCK (NBL-2) Epitherial-like cell line established from normal kidney of dog, susceptible for many viral species.
dog kidney JCRB0717 MDCK.P3 normal kidney, MDCK derivative, no serum required
dog:lung          Top
dog lung JCRB1453 CLAC Canine lung adenocarcinoma cell line including cancer stem cells (0.75%) in sidepopulation (SP).
goat:esophagus          Top
Japan Domestic use only goat esophagus JCRB9037 Ch 1 Es Fibroblastic cell line from normal fetal goat esophagus.
guinea pig:embryo          Top
guinea pig embryo JCRB9036 104C1 fetal carcass, benzo(a)pyrene transformed, diploid
guinea pig:hemo-lymphocytic          Top
guinea pig hemo-lymphocytic IFO50210 L2C Leukemic cells derived from Guinea pig maintainable only by transplantation.
hamster, Chinese:lung          Top
hamster, Chinese lung JCRB1105 AIG anchorage-independent mutant of CHL
hamster, Chinese lung JCRB0030 CHL/IU(IVGT) Chinese hamster lung cells. Standard cell line for chromosome aberation test.
hamster, Chinese lung JCRB1102 cs-17-25 Temperature sensitive mutant of Chinese hamster lung cell line.
hamster, Chinese lung JCRB1103 cs-19-36 Temperature sensitive mutant of Chinese hamster lung cell line.
hamster, Chinese lung JCRB1104 cs-20-5 temperature sensitive mutant of Chinese hamster lung cell line.
hamster, Chinese lung JCRB1096 hs-103-3 Temperature sensitive mutant of Chinese hamster lung cell line.
hamster, Chinese lung JCRB1097 hs-164-2 Temperature sensitive mutant of Chinese hamster lung cell line.
hamster, Chinese lung JCRB1098 hs-171-1 Temperature sensitive mutant of Chinese hamster lung cell line.
hamster, Chinese lung JCRB1099 hs-172-3 Temperature sensitive mutant of Chines hamster lung cell line.
hamster, Chinese lung JCRB1100 hs-211 Temperature sensitive mutant of Chinese hamster lung cell line.
hamster, Chinese lung JCRB1101 hs-222-3 temperature sensitive mutant of Chinese hamster lung cell line.
hamster, Chinese lung JCRB0626 TG1 V79 derivative, 6-thioguanine-resistant
hamster, Chinese lung JCRB0603 V79 fibroblast
hamster, Chinese lung IFO50082 V79 379A lung, fibroblast, widely used in somatic genetics
hamster, Chinese lung JCRB0707 V79 HPRT~ V79 derivative, HPRT-deficient
hamster, Chinese lung JCRB0219 V79-6TG 6-thioguanine-resistant V79 cell line
hamster, Chinese lung JCRB0119 YG10003 salmonella O-acetyltransferase gene introduced CHL cells
hamster, Chinese lung JCRB0120 YG10007 human monomorphic N-acetyltransferase gene introduced CHL cells
hamster, Chinese lung JCRB0121 YG10008 human polymorphic N-acetyltransferase gene transfected CHL cells
hamster, Chinese:ovary          Top
hamster, Chinese ovary JCRB0136.2 CHO(pMAM-HSluc) pMAM-HSluc transfected CHO-K1, HSP 70B gene promoter and luciferase reporter gene introduced
hamster, Chinese ovary JCRB0136.1 CHO(pMAM-luc) pMAM-luc transfected CHO-K1, luciferase activated by dexamethasone
hamster, Chinese ovary JCRB9018 CHO-K1 subclone of CHO (Chainese hamster ovary) cells
hamster, Chinese ovary IFO50414 CHO-K1 CHO-K1 cells are useful for isolation of nutritionally deficient mutants.
hamster, Chinese ovary JCRB0218 CHO/HGPRT HGPRT deficient chinese hamster ovary (CHO) cells.
hamster, Chinese ovary JCRB1616 hTf/CHO-S #17 This cell line produce human transferrin.
hamster, Chinese ovary JCRB1629 hTf/CHO-S #17/sf This cell line produce human transferrin (cell freezed by 10% DMSO+90%FBS).
hamster, Chinese ovary JCRB1629.01 hTf/CHO-S #17/sf This cell line produce human transferrin (cell freezed by Cryoprotective Medium).
hamster, Chinese ovary JCRB1631 hTf/CHO-S #29/sf This cell line produce human transferrin (cell freezed by 10% DMSO + 90% FBS).
hamster, Chinese ovary JCRB1631.01 hTf/CHO-S #29/sf This cell line produce human transferrin (cell freezed by Cryoprotective Medium).
hamster, Chinese ovary JCRB1636 pREP4 c/CHO-S #5/sf pREP4-cont transfected CHO-S cells (cell freezed by 10% DMSO + 90% FBS).
hamster, Chinese ovary JCRB1636.01 pREP4 c/CHO-S #5/sf pREP4-cont transfected CHO-S cells (cell freezed by Cryoprotective Medium).
hamster, Chinese ovary JCRB1626 pREP4 cont/CHO-S #5 pREP4-cont transfected CHO-S cells (cell freezed by 10% DMSO + 90% FBS).
hamster, Syrian:embryo          Top
hamster, Syrian embryo JCRB0217 DSPT200 fetus fibroblast transformed cell
hamster, Syrian embryo IFO50018 NIL transformed from hamster fibroblast
hamster, Syrian embryo IFO50426 NIL-SF2 NIL subline adapted to serum-free medium
hamster, Syrian embryo IFO50367 SHOK This cell line is useful for transformation assay.
hamster, Syrian:hemo-lymphocytic          Top
hamster, Syrian hemo-lymphocytic JCRB1362 HCT-2 Hamster spleen lymphocytes transformed by human T-cell leukemia virus type I.
hamster, Syrian hemo-lymphocytic JCRB1208 HM-1 Hamster macrophage cell line from Syrian hamster transplanted with human umbilical cord leukocytes.
hamster, Syrian:kidney          Top
hamster, Syrian kidney JCRB9020 BHK-21(C-13) kidney, subclone of BHK-21
hamster, Syrian:lung          Top
hamster, Syrian lung JCRB0221 HT100 lung, new born
hamster, Syrian:melanoma          Top
hamster, Syrian melanoma JCRB9087 RPMI 1846 melanotic melanoma
human:adrenal cortex          Top
human adrenal cortex JCRB9069 SW-13 Human adenocarcinoma derived from adrenal cortex.
human:bile duct          Top
human bile duct JCRB1657 HuCCA-1 Human cell line derived from cholangiocarcinoma.
human bile duct JCRB1775 KKK-D068 Human well differentiated tubular adenocarcinma cell line established from biliary tract. (with micropapillary foci)
human bile duct JCRB1777 KKK-D131 Human well differentiated tubular adenocarcinoma cell line established from biliary tract.
human bile duct JCRB1778 KKU-023 Human well differentiated cholangiocarcinoma cell line established from biliary tract.
human:bladder          Top
human bladder JCRB0710 EJ-1 The cell line EJ-1 was identified to be the same cell line as the T24.
human bladder JCRB1148 KMBC-2 Urinary bladder cancer cell line
human bladder JCRB0711 T24 urinary bladder carcinoma
human:blood          Top
human blood JCRB1972 Kit225 IL-2 dependent T-cell chronic lymphocytic leukemia (T-CLL) cell line
human:bone marrow stroma          Top
human bone marrow stroma IFO50477 FS-1 This cell line produces IL-6 and SCF into its supernatant. Although this cell line was reported as immortalized cell line, the ampoules preserved in the cell bank hardly proliferated.
human:cartilage          Top
human cartilage JCRB1137 UE6E7TC-4 Human immortalized mesenchymal cells derived from dedifferentiated chondrocyte, expressing mesenchymal stem cell markers.
human:cerebral tumor          Top
human cerebral tumor JCRB1868 AT/RT atypical teratoid/rhabdoid tumor
human:colon          Top
human colon IFO50483 CCD-33Co Human fibroblast cell line established from normal colon. The ampoules preserved in the cell bank hardly proliferate.
human colon JCRB0208 CCK-81 adenocarcinoma
human colon JCRB0257 CoCM-1 Human tumor cell line of the moderately differentiated adenocarcinoma from descending colon.
human colon JCRB0226 COLO201 adenocarcinoma
human colon JCRB0225 COLO320 DM Human colon carcinoma cell line with double minute chromosomes.
human colon JCRB9094 DLD-1 adenocarcinoma
human colon JCRB1998 KE-24 poorly differentiated adenocarcinoma (signet-ring cell type) established from primary tumor.
human colon JCRB4003 KE-43 moderately differentiated adenocarcinoma established from primary tumor. Transition to poorly differentiated adenocarcinoma by passage.
human colon JCRB4004 KE-43C4 Well-differentiated adenocarcinoma obtained by cloning KE-43
human colon JCRB9083 LoVo adenocarcinoma, carcinoembryonic antigen-producing
human colon IFO50067 LoVo adenocarcinoma, carcinoembryonic antigen-producing
human colon JCRB1339 NCC-CoC-K115B Human B-cell line (transformed by EBV) derived from colon cancer patient.
human colon JCRB1333 NCC-CoC-K115L Human colon cancer cell line (metastasis peripheral lymph node).
human colon JCRB1320 NCC-CoC-K115P Human colon cancer cell line.
human colon JCRB1022 OUMS-23 A human colon carcinoma cell line established from metastatic pericardial fluid.
human colon JCRB1963 UCCA-21 Derived from colorectal cancer with ulcerative colitis. Isolated as well-differentiated adenocarcinoma by cloning. Paneth cells included.
human colon JCRB0224 WiDr adenocarcinoma
human colon IFO50043 WiDr adenocarcinoma
human:duodenum          Top
human duodenum JCRB1946 AkuNEC Cachexia-inducing cell line, (established from duodenal neuroendocrine carcinoma TCC-NECT-2)
human duodenum JCRB1916 TCC-NECT-2 Duodenal neuroendocrine tumor. Derived from metastatic site: Ascites.
human:embryo          Top
human embryo IFO50297 HE-1 Normal diploid fibroblasts with limited life span.
human embryo JCRB0432 KMS-6 fibroblast, normal diploid
human embryo JCRB0433 KMST-6 fibroblast, immortalized by 60Co irradiation, derivative of KMS-6
human embryo JCRB0220 NTI-4 Normal human fibroblast.
human embryo JCRB0222 NTI-5 Normal human cells.
human embryo JCRB1051 OUMS-24/P6X Human normal cells immortalized by pCDM8-p53 and X-ray irradiation.
human embryo JCRB1006.0 OUMS-36 Normal human embryo fibroblast cell.
human embryo JCRB1006.1 OUMS-36T-1 hTRT gene transfected normal human embryo fibroblast cell line.
human embryo JCRB1006.1F OUMS-36T-1F fibroblast, immortalized by hTRT, derivative of OUMS-36
human embryo JCRB1006.2 OUMS-36T-2 hTRT gene transfected normal human embryo fibroblast cell line.
human embryo JCRB1006.2F OUMS-36T-2F fibroblast, immortalized by hTRT, derivative of OUMS-36
human embryo JCRB1006.3 OUMS-36T-3 hTRT gene transfected normal human embryo fibroblast cell line.
human embryo JCRB1006.3F OUMS-36T-3F Human normal diploid cells transfected with hTRT gene
human embryo JCRB1006.4 OUMS-36T-4 hTRT gene transfected normal human embryo fibroblast cell line.
human embryo JCRB1006.4F OUMS-36T-4F Immortalized normal human cell with hTRT gene.
human embryo JCRB1006.5 OUMS-36T-5 hTRT gene transfected normal human embryo fibroblast cell line.
human embryo JCRB1006.5F OUMS-36T-5F fibroblast, immortalized by hTRT, derivative of OUMS-36
human embryo JCRB1006.6 OUMS-36T-6 hTRT gene transfected normal human embryo fibroblast cell line.
human embryo JCRB1006.6F OUMS-36T-6F fibroblast, immortalized by hTRT, derivative of OUMS-36
human embryo JCRB1006.7 OUMS-36T-7 hTRT gene transfected normal human embryo fibroblast cell line.
human embryo JCRB1006.7F OUMS-36T-7F Human normal fibroblast transformed with hTRT gene.
human embryo JCRB1006.8 OUMS-36T-8 hTRT gene transfected normal human embryo fibroblast cell line.
human embryo JCRB1006.8F OUMS-36T-8F fibroblast, immortalized by hTRT, derivative of OUMS-36
human:epidermoid carcinoma          Top
human epidermoid carcinoma JCRB0004 A-431 epidermoid carcinoma, high expression of EGF-receptor
human epidermoid carcinoma JCRB9009 A-431 epidermoid carcinoma, high expression of EGF-receptor
human epidermoid carcinoma IFO50411 A-431 epidermoid carcinoma, high expression of EGF receptor
human:esophagus          Top
human esophagus JCRB1883 KE-3 Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
human esophagus JCRB1911 KE-5 Human well differentiated squamous cell carcinoma cell line established from esophageal cancer.
human esophagus JCRB1915 KE-6 Human well differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB1483 KYAE-1 Human esophageal adenocarcinoma cell line.
Japan Domestic use only human esophagus JCRB1595 KYAE-2 Human esophageal adenocarcinoma cell line.
Japan Domestic use only human esophagus JCRB1064 KYSE110 Poorly differentiated squamous carcinoma cell line from human esophagus cancer.
Japan Domestic use only human esophagus JCRB1449 KYSE1140 Human poorly differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB1457 KYSE1170 Human poorly differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB1421 KYSE1190 Human poorly differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB1444 KYSE1230 Human spindle cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB1456 KYSE1240 Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB1462 KYSE1250 Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB1434 KYSE1260 Human poorly differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB1063 KYSE140 Human esophageal cancer cell line.
Japan Domestic use only human esophagus JCRB1432 KYSE1440 Human poorly differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB1095 KYSE150 Poorly differentiated squamous carcinoma cell line from human esophageal cancer.
Japan Domestic use only human esophagus JCRB1082 KYSE170 Human squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB1083 KYSE180 Human well differentiated squamous cell carcinoma from esophageal cancer.
Japan Domestic use only human esophagus JCRB1460 KYSE1860 Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB1426 KYSE190 Human well differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB1086 KYSE220 Human squamous cell carcinoma from esophagus.
Japan Domestic use only human esophagus JCRB1468 KYSE2270 Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB1472 KYSE2300 Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB1424 KYSE2400 Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB1087 KYSE270 Human squamous cell carcinoma from esophagus cancer.
Japan Domestic use only human esophagus JCRB1467 KYSE2710 Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB1452 KYSE2780 Human squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB1469 KYSE2880 Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB0188 KYSE30 Well differentiated human suamous cell carcinoma from esophageal cancer.
Japan Domestic use only human esophagus JCRB1463 KYSE3210 Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB1425 KYSE3410 Human squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB1428 KYSE350 Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB1495 KYSE3650 Human squamous cell carcinoma cell line established from recurrent cancer (esophageal cancer).
Japan Domestic use only human esophagus JCRB1481 KYSE3940 moderate differenciated squamous cell carcinoma, stage 3
Japan Domestic use only human esophagus JCRB1419 KYSE410 Human poorly differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB1430 KYSE450 Human well differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB0189 KYSE50 Stop providing for the issue of quality control. (Please contact us for more information) Poorly differentiated human squamous cell carcinoma from esophageal cancer.
Japan Domestic use only human esophagus JCRB1436 KYSE510 Human well differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB1439 KYSE520 Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB1443 KYSE590 Human well differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB0190 KYSE70 Poorly differentiated human squamous cell carcinoma from esophageal cancer.
Japan Domestic use only human esophagus JCRB1445 KYSE770 Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB1418 KYSE790 Human well differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB1422 KYSE850 Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
Japan Domestic use only human esophagus JCRB1417 KYSE960 Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer.
human esophagus JCRB0262 T.T Human squamous cell carcinoma derived from esophageal cancer.
human esophagus JCRB0261 T.Tn Human squamous cell carcinoma from oral cavity via mouse transplantation.
Japan Domestic use only human esophagus JCRB1512 TYUC-1 Human esophageal small cell carcinoma cell line established from mouse xenograft.
human:glioblastoma          Top
human glioblastoma IFO50492 AM-38 glioblastoma, GFAP and S-100-positive, ACNU(a cancer chemotherapy drug)-sensitive
human:glioma          Top
human glioma IFO50356 KNS-42 glioma, GFAP-positive, S-100 and NSE-negative
human glioma JCRB1569 NP 5 Human cell line derived from human glioma.
human:HeLa-contaminant          Top
human HeLa-contaminant JCRB9066 Chang Liver The Chang Liver cell line has been identified historically as a subline of the HeLa.
human HeLa-contaminant IFO50016 Chang Liver Hela markers*
human HeLa-contaminant JCRB1070 HSGc-C5 Human undifferentiated carcinoma cell line from floor of mouth (HeLa evidences observed).
human HeLa-contaminant JCRB0073 J-111 The cell line deposited as a human acute monocytic leukemia but many data show this cell line is a subline of the HeLa.
human HeLa-contaminant IFO50005 J-111 HeLa markers*
human HeLa-contaminant JCRB9027 KB The cell line KB has been known that this cell line is a subline of the HeLa.
human HeLa-contaminant IFO50004 WISH Cells were reported to established from human aminion but later HeLa markers were observed.
human:hemo-lymphocytic          Top
human hemo-lymphocytic JCRB0097 A4/Fuk lymphoma, malignant, B-cell, non-Hodgkin's, IgM kappa-producing
human hemo-lymphocytic JCRB0117 B104 Human B cell lymphoma cell line with EBNA(-). IgD and IgM were expressed on the surface of cells.
human hemo-lymphocytic JCRB0071 BALL-1 Acute lymphoblastoid leukemia (ALL) cell line from human.
human hemo-lymphocytic JCRB0033 CCRF-CEM leukemia, acute T lymphoblastic
human hemo-lymphocytic JCRB9023 CCRF-CEM Human cell line established from patient with acute lymphoblastic leukemia.
human hemo-lymphocytic IFO50412 CCRF-CEM leukemia, acute T lymphoblastic
human hemo-lymphocytic JCRB0031 CCRF-HSB2 Human T-lymphoblastic leukemia cell line from implanted tumor in Syrian hamster.
human hemo-lymphocytic IFO50026 CCRF-SB Karyotypes appeared normal diploid. This cell line does not synthesize immunogloblins.
human hemo-lymphocytic IFO50430 CMK-11-5 This cell line posseses more mature characteristics than CMK-86 cells.
human hemo-lymphocytic IFO50428 CMK-86 This cell line expresses GPIIb/IIIa. Contains alpha-granule. Contains platelet peroxidase activity.
human hemo-lymphocytic JCRB1067 CPT-K5 Mutant cell line derived from human ALL cell line, RPMI8402.
human hemo-lymphocytic JCRB1344 delta-47 Human myeloma cell line secreting IgD.
human hemo-lymphocytic JCRB1337 DL-40 Ki-1-positive T-cell lymphoma cell line.
human hemo-lymphocytic JCRB1346 FLAM-76 Interleukin-6-dependent human myeloma cell line from an agressive nonsecretory plasma cell leukemia.
human hemo-lymphocytic JCRB1335 HD-70 Human Hodgkin's lymphoma cell line of B-cell origin.
human hemo-lymphocytic JCRB0062 HEL leukemia, erythroid
human hemo-lymphocytic IFO50022 HL-60 IFO strain exhibits more rapid growth compared to the original HL-60 strain. IFO strain does not respond to DMSO or TPA for differentiation unlike to original HL-60 strain.
human hemo-lymphocytic JCRB0085 HL60 Promyelocytic cell line differentiated to neutrophils or macropahges by tumor promoters, vitamne D3 or cytekines. The cell line can be used for the research of the differenciation induction or analysis of some oncogenes.
human hemo-lymphocytic JCRB0163 HL60(S) Promyeloblastic cell line differentiated to neutrophils or macropahges by tumor promoters, vitamne D3 or cytekines. This HL60(S) has been independently obtained by Dr. Ishida,S. and Dr. Shudo,K.
human hemo-lymphocytic JCRB0006 HL60RG Subline of the HL60 having faster growth rate but the capabilities of the differentiation by TPA or etc were declined.
human hemo-lymphocytic JCRB0041 HLCL-1 lymphocyte, peripheral
human hemo-lymphocytic JCRB9062 HS-Sultan established as plasmacytoma, but revealed as derivative of Jiyoye cell line (Burkitt's lymphoma)
human hemo-lymphocytic JCRB0024 IM-9 myeloma, multiple, B lymphoblastic
human hemo-lymphocytic IFO50025 IM-9 IgG-secreting B-lymphoblastic cell line.
human hemo-lymphocytic JCRB0147 JKT-beta-del The JKT-beta-del cell line isolated from the Jurkat cells{5011} by a cell sorter and lacks the surface expression of the T-cell receptor alpha/beta/CD3 complex.
human hemo-lymphocytic JCRB0019 K562 Highly undifferentiated and granurocytic myelogenous leukemia cell line from blast crisis.
human hemo-lymphocytic JCRB1002 K562/ADM Adriamycine resistant derivative of K562 cell line.
human hemo-lymphocytic JCRB1003 Kasumi-1 A novel leukemia cell line with an t8;21 chromosome translocation established from a patient attaked by acute myeloid leukemia(AML).
human hemo-lymphocytic JCRB1410 Kasumi-10 B cell leukemia
human hemo-lymphocytic JCRB0161 Kasumi-4 A novel human leukemia cell line established from a patient with chronic myelogenous leukaemia (CML) in blast crisis.
human hemo-lymphocytic JCRB1398 Kasumi-5 T cell leukemia
human hemo-lymphocytic JCRB1401 Kasumi-7 B cell leukemia
human hemo-lymphocytic JCRB1403 Kasumi-8 B cell leulemia
human hemo-lymphocytic JCRB1409 Kasumi-9 B cell leukemia
human hemo-lymphocytic JCRB1411 KasumiA-541 mixed lineage leukemia
human hemo-lymphocytic JCRB1416 KasumiA-554 myeloid leukemia secondary to ATL
human hemo-lymphocytic JCRB1415 KasumiA-568 myeloblastic leukemia
human hemo-lymphocytic JCRB1317 KCL-22 Human myeloid cell line from chronic myelocytic leukemia.
human hemo-lymphocytic JCRB0065 KG-1 leukemia, acute myeloblastic
human hemo-lymphocytic JCRB9051 KG-1 leukemia, acute myelogenous
human hemo-lymphocytic JCRB0165 KHM-10B Human Bukitt's lymphoma, ALL-L3 cell line. HLA-DR,CD19 and surface immunoglobulin(mu, lambda) positive. Ig gene rearrangements observed.
human hemo-lymphocytic JCRB1394 KHM-2B Human acute B-cell lymphocytic leukemia cell line with two translocations t(8;14) and t(14;18).
human hemo-lymphocytic JCRB1065 Ki-JK Human mononuclear cells with multiple nucleoli from lymphoma patient.
human hemo-lymphocytic JCRB1180 KMM-1 human myeloma cell line
human hemo-lymphocytic JCRB0123 KO52 leukemia, acute myeloblastic
human hemo-lymphocytic JCRB0104 KU812 leukemia, chronic myeloid
human hemo-lymphocytic IFO50363 KU812 leukemia, chronic myeloid
human hemo-lymphocytic JCRB0104.1 KU812E leukemia, chronic myeloid
human hemo-lymphocytic JCRB0104.2 KU812F leukemia, chronic myeloid
human hemo-lymphocytic JCRB0105 KY821 leukemia, acute myeloid
human hemo-lymphocytic JCRB0105.1 KY821A3 leukemia, acute myeloid, subclone of KY821
human hemo-lymphocytic JCRB0114 LC4-1 leukemia, acute non T lymphoblastic
human hemo-lymphocytic IFO50151 MEG-01 Contains Ph1 chromosome. Expresses megakaryoblastic markers as GPIIb/IIIa, GPIb, FVIII-related antigens, and also CD9, CDw14. It is reported that MEG-01 cells produced platelet-like particles. Morphological changes by phorbol ester.
human hemo-lymphocytic IFO50473 MEG-01s This cell line is useful for studying the differentiation and maturation of megakaryocyts.
human hemo-lymphocytic IFO50294 MEG-01SSF leukemia, chronic megakaryoblastic, MEG-01s-derivative adapted to serum-free medium
human hemo-lymphocytic IFO50478 MEG-A2 This cell line is useful for studying the differentiation and maturation of megakaryocyts.
human hemo-lymphocytic JCRB1404 Minami-1 follicular B cell lymphoma
human hemo-lymphocytic JCRB1405 Minami-2 B cell lymphoma (Burkitt type)
human hemo-lymphocytic JCRB1325 MKPL-1 A megakaryoblastic leukemia cell line from human acute myeloblastic leukemia.
human hemo-lymphocytic JCRB0146 MLMA The cells are IgD, IgM positive, hairy B-cells from human malignant lymphoma patient.
human hemo-lymphocytic JCRB9048 MOLT-3 leukemia, acute lymphoblastic
human hemo-lymphocytic JCRB9031 MOLT-4 leukemia, acute T lymphoblastic
human hemo-lymphocytic IFO50362 MOLT-4 leukemia, acute T lymphoblastic
human hemo-lymphocytic JCRB0021 MOLT-4F leukemia, acute T lymphoblastic
human hemo-lymphocytic IFO50513 MTA leukemia, NK-like T cell line
human hemo-lymphocytic JCRB0158.0 MY Human bone marrow mononuclear cells derived from a patient having acute biphenotypic leukemia.
human hemo-lymphocytic JCRB0158.1 MY-M12 Subclone of the MY, human bone marrow mononuclear cells.
human hemo-lymphocytic JCRB0158.2 MY-M13 Subclone of the MY cells, human bone marrow mononulcear cells.
human hemo-lymphocytic IFO50479 NAGL-1 The CDR III of this line has been sequenced.
human hemo-lymphocytic JCRB1332 NALL-1 Human 'null' cell from ALL cell line.
human hemo-lymphocytic JCRB1475 Nalm-6-MSH+ Human cell line derived from B cell leukemia. (MSH+, POL(WT), TK+/-)
human hemo-lymphocytic IFO50040 Namalwa This cell line produce interferon.
human hemo-lymphocytic IFO50039 NC-37 lymphoblast, Contamination of Raji cells has been suspected.
human hemo-lymphocytic IFO50525 NCO2 Human myelogenous leukemia cell line.
human hemo-lymphocytic IFO50476 NKM-1 leukemia, acute myeloid, myeloid leukemia cells, responsive to G-CSF and M-CSF for growth
human hemo-lymphocytic IFO50474 NOMO-1 This cell line is useful for studying the differentiation and maturation of monocytes.
human hemo-lymphocytic JCRB1069 NOMO-1/ADM leukemia, acute monocytic, adriamycin-resistant derivative of NOMO-1
human hemo-lymphocytic IFO50475 NOMO-1s This cell line is useful for studying the differentiation and maturation of monocytes.
human hemo-lymphocytic JCRB0095 P32/ISH lymphoma, Burkitt's
human hemo-lymphocytic JCRB1345 PALL-2 Ph1 chromosome-positive human acute lymphoblastic leukemia cell line.
human hemo-lymphocytic JCRB0830 PEER Human lymphoid cell line from a case of T-leukemia lacks some typical cell surface properties of T cells.
human hemo-lymphocytic JCRB9012 RAJI lymphoma, Burkitt's
human hemo-lymphocytic IFO50046 Raji lymphoma, Burkitt's
human hemo-lymphocytic JCRB9119 Ramos(RA1) lymphoma, Burkitt's (EBV negative)
human hemo-lymphocytic JCRB1334 RC-K8 A human lymphoma cell line with t(11;14) chromosome abnormality.
human hemo-lymphocytic JCRB0035 RPMI 1788 established from normal blood, IgM secreting
human hemo-lymphocytic IFO50037 RPMI 1788 established from normal blood, IgM secreting
human hemo-lymphocytic JCRB0034 RPMI 8226 myeloma, multiple
human hemo-lymphocytic IFO50013 RPMI 8226 Ig lambda light chain-secreting.
human hemo-lymphocytic JCRB0115 SCC-3 Human monocytic cell line expressing Interleukin-2 receptor.
human hemo-lymphocytic JCRB1170 SKNO-1 a GM-CSF dependent cell line with an t8,21 chromosome translocation estabulished from a patient attacked by acute myeloid leukemia(AML)
human hemo-lymphocytic JCRB0159 SLVL Human villous lymphoma B-cell line from splenic B-cell lymphoma.
human hemo-lymphocytic JCRB1384 STR-428 Human HHV-8 negative malignant effusion lymphoma (DLBCL).
human hemo-lymphocytic JCRB0112 THP-1 Human acute monocytic leukemia.
human hemo-lymphocytic JCRB0112.1 THP-1 Human acute monocytic leukemia.
human hemo-lymphocytic JCRB0157 TK Human B-cell lymphoma cell line with near-triploid chromosomes with t(14;18) and p53 gene point mutation.
human hemo-lymphocytic JCRB1206 TK Brain lymphoma cell line.
human hemo-lymphocytic IFO50516 TMD5 leukemia, acute B lymphoblastic, double Philadelphia chromosomes
human hemo-lymphocytic IFO50038 U-937 lymphoma, diffuse histiocytic, monocyte-like characteristics
human hemo-lymphocytic JCRB9021 U937 lymphoma, diffuse histiocytic, monocyte-like characteristics
human hemo-lymphocytic JCRB0116.1 U937 cl1-14 lymphoma, histiocytic, highly susceptible clone of U937 for HIV
human hemo-lymphocytic JCRB0116.2 U937 cl1-22 lymphoma, histiocytic, low susceptible clone of U937 for HIV
human:hepatoblastoma          Top
human hepatoblastoma JCRB0401 HUH-6 Clone 5 Human hepatoblastoma cell line from an infant.
human:intestine          Top
human intestine JCRB9076 FHs 74 Int Human fetal small intestin cells.
human:kidney          Top
human kidney JCRB9068 293 transformed embryonal kidney by adenovirus (type5)
human kidney JCRB0801 Caki-1 renal clear cell carcinoma
human kidney JCRB9065 G-401 Rhabdoid tumor of kidney (formerly classified as Wilms' tumor)
human kidney JCRB9070 G-402 renal leiomyoblastoma
human kidney JCRB1484 JMU-RTK-2 Malignant rhabdoid tumor of the kidney cell line.
human kidney JCRB1150 KMPC-3 Human renal pelvis.
human kidney JCRB1010 KMRC-1 Human tumor cell line from kidney. Clear cell renal carcinoma cell line.
human kidney JCRB1011 KMRC-2 Human tumor cell line from kidney. Clear cell renal carcinoma cell line.
human kidney JCRB1071 KMRC-20 Human renal carcinoma cell line from kidney.
human kidney JCRB1012 KMRC-3 Human tumor cell line from kidney. Clear cell renal carcinoma cell line. The growth is extremely slow.
human kidney JCRB1014 KMRM-M1 Human renal cancer cell line metastasized to muscle.
human kidney JCRB0813 VMRC-RCW renal cell carcinoma
human kidney JCRB0827 VMRC-RCZ renal carcinoma
human:leukemia          Top
human leukemia JCRB1800 BALM-23 B cell leukemia cell line, ALL-L2 cell line, hypercalcemia
human leukemia JCRB1843 BALM-24 B cell leukemia cell line, ALL-L3 cell line, t(8;14)(q24.1;q32)
human leukemia JCRB1782 BALM-7 B cell leukemia cell line
human leukemia JCRB1785 BALM-9 B cell leukemia cell line
human leukemia JCRB0032 CCRF-SB leukemia, acute B lymphoblastic
human leukemia JCRB1846 EEB Human cell line derived from erythroblastic leukemia.
human leukemia JCRB1395 Kasumi-2 B cell precursor leukemia
human leukemia JCRB1004 Kasumi-3 A novel human leukemia cell line established from blast cells of a patient attaked by myeloperoxidase-negative acute leukemia.
human leukemia JCRB1024 Kasumi-6 Human acute myeloid leukemia cell line with dominant negative mutation in the C/EBP alpha gene.
human leukemia JCRB0156 KHYG-1 Human natural killer cell line with a p53 point mutation as a model for p53-associated leukemogenesis and a model for differentiation of NK/T cells.
human leukemia JCRB1810 MOLM-13 Human acute monocytic leukemia (AML-M5a) cell line. MOLM-13 was established from the same donor as MOLM-14.
human leukemia JCRB1812 MOLM-14 Human acute monocytic leukemia (AML-M5a) cell line. MOLM-14 was established from the same donor as MOLM-13.
human leukemia JCRB1815 MOLM-16 Megakaryoblastic leukemia cell line derived from minimally differentiated acute leukemia (AML-M0) with myeloid/NK precursor phenotype.
human leukemia JCRB1807 MOLM-6 Human multiple leukemia cell line with diverse myeloid and/or megakaryoblastic characteristics
human leukemia JCRB1822 NALM-19 Biphenotypic (B-cell and myeloid cell features) leukemic cell line.
human leukemia JCRB1823 NALM-20 Biphenotypic (B-cell and myeloid cell features) t(9;22)-positive leukemic cell line.
human leukemia JCRB1825 NALM-21 Biphenotypic (B-cell and myeloid cell features) t(9;22)-positive leukemic cell line. Recurrence of the same patient as NALM-20.
human leukemia JCRB1826 NALM-24 Biphenotypic (B-cell and myeloid cell features) t(9;22)-positive acute lymphoblastic leukemia cell line. From the same patient as NALM-25
human leukemia JCRB1828 NALM-25 Biphenotypic (B-cell and myeloid cell features) t(9;22)-positive acute lymphoblastic leukemia cell line. Derived from the same patient as NALM-24
human leukemia JCRB1854 NALM-29 Biphenotypic (B-cell and myeloid cell features) t(9;22)(q34;q11)-positive B-cell precursor cell line establish from acute leukemia patient.
human leukemia JCRB1858 NALM-30 Biphenotypic features carrying myeloperoxidase mRNA and protein with complex Philadelphia (Ph) chromosome, t(9;22;10)(q34;q11;q22), cell line establish from acute leukemia patient. Derived from the same patient as NALM-27, NALM-28, NALM-31, NALM-32.
human leukemia JCRB1856 NALM-37 B-cell precurrsor (BCP) acute lymphoblastic leukemia (ALL) cell line. Derived from the same patient as NALM-36
human leukemia JCRB0094 P30/OHK leukemia, acute non T non B lymphoblastic
human leukemia JCRB0091 P31/FUJ leukemia, acute monocytic
human leukemia JCRB1319 PL-21 Human myeloid cell line derived from an acute promyelocytic leukemia.
human leukemia JCRB0118 SKM-1 myelo dysplastic syndrome
human leukemia JCRB0086 TALL-1 leukemia, acute T lymphoblastic
human:liver cancer          Top
human liver cancer JCRB0403 HuH-7 Well differentiated human hepato cellular carcinoma cell line.
human:liver, gallbladder          Top
human liver, gallbladder IFO50069 Alexander cells hepatoma, HBs antigen-positive. This cell line is the same cell line as PLF/PRF/5 (other name of PLC/PRF/5).
human liver, gallbladder JCRB1054 Hep G2 Hepatoblastoma-derived (previously thought to be hepatocellular carcinoma-derived) cell line.
human liver, gallbladder JCRB0404 HLE hepatoma, non-differentiated
human liver, gallbladder JCRB0405 HLF hepatoma, non-differentiated
human liver, gallbladder JCRB0425 HuCCT1 Human liver bile duct carcinoma cell line.
human liver, gallbladder JCRB0199 huH-1 Human hepatoma cell line.
human liver, gallbladder JCRB0426 HuH28 Human liver, bile duct carcinoma cell line.
human liver, gallbladder JCRB1028 JHH-2 Human hepatocellular carcinoma cell line (Ed.II).
human liver, gallbladder JCRB0435 JHH-4 Human hepatocellular carcinoma cell line.
human liver, gallbladder JCRB1029 JHH-5 Human hepatocellular carcinoma (Ed.I) established from small liver cancer.
human liver, gallbladder JCRB1030 JHH-6 Human hepatocellular carcinoma cell line.
human liver, gallbladder JCRB1031 JHH-7 HBV integrated human hepato cellular carcinoma cell line.
human liver, gallbladder JCRB1551 KKU-055 Human poorly differentiated cholangiocarcinoma cell line established from biliary tract.
human liver, gallbladder JCRB1568 KKU-100 Human poorly differentiated cholangiocarcinoma cell line established from biliary tract.
human liver, gallbladder JCRB1557 KKU-213 Human mixed (papillary and non-papillary) cholangiocarcinoma cell line established from biliary tract.
human liver, gallbladder JCRB1772 KKU-452 Human poorly differentiated cholangiocarcinoma cell line established from biliary tract.
human liver, gallbladder JCRB0160 LI90 Ito (fat-storing) cells, stellate-shaped mesenchymal cells that exist in the space of Disse of the liver and contain many fat droplets in cytoplasm.
human liver, gallbladder JCRB1033 NOZ Human gallbladder carcinoma cell line.
human liver, gallbladder JCRB0191 OCUG-1 Human gall bladder carcinoma cell line producing TA-4 antigen.
human liver, gallbladder JCRB1032 OZ Human bile duct cell line established from ascites of the tumor patient who had differentiated adenocarcinoma.
human liver, gallbladder JCRB0406 PLC/PRF/5 hepatoma, HBs antigen-positive
Japan Domestic use only human liver, gallbladder JCRB1501 TYBDC-1 Human bile duct cancer cell line.
Japan Domestic use only human liver, gallbladder JCRB1499 TYGBK-1 Human gall bladder cancer cell line.
Japan Domestic use only human liver, gallbladder JCRB1590 TYGBK-8 Human gall bladder cancer cell line.
human:lung          Top
human lung JCRB0815 ABC-1 adenocarcinoma
human lung JCRB9101 CCD-14Br bronchus, diploid
human lung JCRB0820 EBC-1 squamous cell carcinoma
human lung IFO50089 Flow2000 Normal diploid fibroblasts with limited life span.
human lung JCRB1080.0 HARA Human lung squamous cell carcinoma with PTHrP expression.
human lung IFO50074 HFL1 Normal diploid fibroblasts with limited life span.
human lung JCRB9054 IMR-90 Normal human fibroblast.
human lung JCRB0519 IMR-90-40 Normal human fibroblast.
human lung JCRB0235 Lu-134-A-H small cell carcinoma, classic type
human lung JCRB0080 LU99 giant cell carcinoma
human lung JCRB9008 MRC-5 fetal lung, normal diploid fibroblast
human lung IFO50073 MRC-5 Normal diploid fibroblasts with limited life span (crisis PDL = 42-46).
human lung JCRB0521 MRC-5-30 fetal lung, normal diploid fibroblast, PDL=about 30
human lung JCRB9060 MRC-9 fetal lung, normal diploid fibroblast
human lung IFO50072 MRC-9 Normal diploid fibroblasts with limited life span (crisis PDL = 44).
human lung JCRB1034 OUS-11 Normal human cell line from lung cancer patient.
human lung JCRB1021 RERF-LC-Ad2 Human cancer cell line, adenocarcinoma.
human lung JCRB0081 RERF-LC-MS adenocarcinoma
human lung JCRB0818 SBC-3 small cell carcinoma, oat cell type
human lung JCRB0819 SBC-5 small cell carcinoma, intermediate
human lung JCRB0506.1 SVts-8 Human normal diploid fibroblast cell line transformed with SV40(ts) early gene. Cell culture at 34 C.
human lung JCRB0501 TIG-1-20 fetal lung, normal diploid fibroblast, TIG-1, PDL=about 20
human lung JCRB0502 TIG-1-30 fetal lung, normal diploid fibroblast, TIG-1, PDL=about 30
human lung JCRB0503 TIG-1-40 fetal lung, normal diploid fibroblast, TIG-1, PDL=about 40
human lung JCRB0504 TIG-1-50 fetal lung, normal diploid fibroblast, TIG-1, PDL=about 50
human lung JCRB0505 TIG-1-60 fetal lung, normal diploid fibroblast, TIG-1, PDL=about 60
human lung JCRB0506 TIG-3-20 Normal fibroblast cell line derived from Japanese fetal lung.
human lung JCRB0511 TIG-7-20 fetal lung, normal diploid fibroblast, TIG-7, PDL=about 20
human lung JCRB0103 VMRC-LCP squamous cell carcinoma
human lung JCRB9042 WI-26 VA4 SV-40 virus transformed human lung cell line.
human lung IFO50075 WI-38 Normal diploid fibroblast with limeted life span. This cell line at around 30 PDL is distributed.
human lung JCRB9057 WI-38 VA13 sub 2 RA fetal lung, SV40 virus transformed, derivative of WI-38
human lung JCRB0518 WI-38-40 Normal primary cells from lung as well as JCRB0517. Now only the JCRB0518 with PDL 40 is available.
human:lung (cancer)          Top
human lung (cancer) JCRB0076 A549 Human adeno carcinoma cell line derived from lung cancer.
human lung (cancer) IFO50153 A549 adenocarcinoma
human lung (cancer) JCRB1080.1 HARA-B HARA cell (human lung squamouse cell carcinoma) established from bone metastasis in nude mouse.
human lung (cancer) JCRB1552 HARA-B4 HARA cell (human lung squamouse cell carcinoma) established from bone metastasis (4 times selection) in nude mouse.
human lung (cancer) JCRB0138 KHM-3S small cell carcinoma, HTLV-1gene integration
human lung (cancer) IFO50358 KNS-62 bronchial squamous carcinoma, metastasis to brain
human lung (cancer) JCRB0258 LC-1 sq squamous cell carcinoma
human lung (cancer) JCRB0169 Lu-134-B Small cell lung carcinoma cell line established through heterotransplanted tumor.
human lung (cancer) JCRB0079 LU65 Human cell line with giant cell carcinoma of lung.
human lung (cancer) JCRB0054 LU65A giant cell carcinoma
human lung (cancer) JCRB0055 LU65B giant cell carcinoma
human lung (cancer) JCRB0056 LU65C giant cell carcinoma
human lung (cancer) JCRB0044 LU99A giant cell carcinoma
human lung (cancer) JCRB0057 LU99B Lung giant cell carcinoma
human lung (cancer) JCRB0058 LU99C Lung giant cell carcinoma.
human lung (cancer) JCRB1081 MS-1-L Human lung small cell carcinoma from pleural effusion.
human lung (cancer) JCRB1343 OKa-C-1 Lung cancer cell line producing both G-CSF and PTHrP.
human lung (cancer) JCRB0077 PC-3 adenocarcinoma, intermediately differentiated
human lung (cancer) JCRB1020 RERF-LC-Ad1 Human lung cancer cell line, adenocarcinoma.
human lung (cancer) JCRB0102 RERF-LC-FM small cell carcinoma, intermediate
human lung (cancer) JCRB0137 RERF-LC-KJ adenocarcinoma, transplantable to SCID mice and frequently metastasize to lymph nodes
human lung (cancer) JCRB1019 RERF-LC-Sq1 Cell line established from human lung carcinoma tissue.
human lung (cancer) JCRB1053 STC 1 Human small cell lung carcinoma.
human lung (cancer) JCRB0814 VMRC-LCD adenocarcinoma
human:lung cancer          Top
human lung cancer JCRB0829 LK-2 squamous cell carcinoma
human lung cancer JCRB0170 Lu-135 Human small cell lung carcinoma cell line.
human:lymph node          Top
Japan Domestic use only human lymph node JCRB1470 SUm/c SUm/c was established from floating in the lymph of the thoracic duct of patients with esophageal squamous cell carcinoma.
human:lymphoblastoid          Top
human lymphoblastoid JCRB1752 XYFMGG16M EBV transformed B-cell lymphoblastoid cell line from human XY female.
human:lymphocyte          Top
human lymphocyte JCRB9063 WIL2-NS B lymphocyte line, from patient with hereditary spherocytic anemia, non-immunoglobulin secreting variant
human:lymphocytic          Top
human lymphocytic IFO50518 KAI3 EBV-infected NK-like cell line, IL-2 dependent
human:lymphoma          Top
human lymphoma JCRB0101 A3/KAW lymphoma, malignant
human lymphoma JCRB1765 Akata-EBV-N Epstein-Barr virus (EBV)-negative cell line established from a Japanese patient with Burkitt’s lymphoma.
human lymphoma JCRB9071 Daudi lymphoma, Burkitt's
human lymphoma JCRB1977 HCF-MLp-N human B-cell line derived from non-Hodgkin's lymphoma, Primary Central Nervous System Lymphoma, PCNSL
human lymphoma JCRB1347 KML-1 Human B-cell lymphoma cell line.
human lymphoma JCRB4016 WILL3 Human diffuse large B-cell lymphoma cell line with two translocations t(14;18)(q32; q21) and t(8;22)(q24;q11).
human:mammary          Top
human mammary JCRB0166 HMC-1-8 A target cell of the T-cell killer clone T(cHMC-1).
human mammary JCRB0134 MCF-7 Human metastatic mammary carcinoma cell line.
human mammary JCRB0628 MRK-nu-1 Human mammary carcinoma cell line.
human mammary JCRB0823 YMB-1 breast cancer, exhibit the same DNA profile as other breast carcinoma cell line ZR-75-1.
human mammary JCRB0825 YMB-1-E breast cancer, exhibit the same DNA profile as other breast carcinoma cell line ZR-75-1.
human:melanoma          Top
human melanoma IFO50276 A2058 malignant melanoma, metastasis to lymph node
human melanoma JCRB0227 C32TG Human 6TG resistant amelanotic melanoma cell line from skin.
human melanoma JCRB9074 G-361 malignant melanoma, skin
human melanoma IFO50009 G-361 This cell line produces melanin.
human melanoma IFO50321 GAK Human malignant melanoma cell line with the production of 5-S-cysteinyldopa.
human melanoma JCRB0180 GAK Human malignant melanoma cell line with the production of 5-S-cysteinyldopa.
human melanoma JCRB1018 HMY-1 Mlignant melanoma cell line.
human melanoma JCRB0066 Mewo malignant melanoma
human melanoma JCRB1041 SEKI Human malignant melanoma cell line.
human melanoma JCRB0074 VMRC-MELG malignant melanoma, colon
human:mesenchymal stem          Top
human mesenchymal stem JCRB1154 UE7T-13 Human bone marrow-derived mesenchymal stem cells.
human:mesenchymal stem cell          Top
human mesenchymal stem cell JCRB1159 UBE6T-15 Human bone marrow-derived mesenchymal stem cells.
human mesenchymal stem cell JCRB1140 UBE6T-6 Human bone marrow-derived mesenchymal stem cells.
human mesenchymal stem cell JCRB1143 UBE6T-7 Human bone marrow-derived mesenchymal stem cells.
Japan Domestic use only human mesenchymal stem cell JCRB1108 UCB408E6E7-31 Human umbilical cord blood-derived mesenchymal stem cells. Not immortalized cell line (limited life span).
human mesenchymal stem cell JCRB1110 UCB408E6E7TERT-33 Human umbilical cord blood-derived mesenchymal stem cells.
Japan Domestic use only human mesenchymal stem cell JCRB1109 UCB408E7-32 Human umbilical cord blood-derived mesenchymal stem cells. Not immortalized cell line (limited life span)
human mesenchymal stem cell JCRB1107 UCBTERT-21 Human umbilical cord blood-derived mesenchymal stem cells.
Japan Domestic use only human mesenchymal stem cell JCRB1160 UE6E7-16 Human bone marrow-derived mesenchymal stem cells. Not immortalized cell line (limited life span).
human mesenchymal stem cell JCRB1149 UE6E7T-11 Human bone marrow-derived mesenchymal stem cells.
human mesenchymal stem cell JCRB1151 UE6E7T-12 Human bone marrow-derived mesenchymal stem cells.
human mesenchymal stem cell JCRB1133 UE6E7T-2 Human bone marrow-derived mesenchymal stem cells.
human mesenchymal stem cell JCRB1147 UE7T-9 Human bone marrow-derived mesenchymal stem cells.
human:muscular system          Top
human muscular system JCRB0525 TIG-2M-30 muscular tissue derived normal diploid fibroblast (not myoblast), PDL=about 30
human:myeloma          Top
human myeloma JCRB0133 KHM-1B myeloma, multiple, with hyperamylasemia.
human myeloma JCRB1179 KMS-11 human myeloma cell line.
human myeloma JCRB1642 KMS-11/BTZ bortezomib-resistant multiple myeloma cell line.
human myeloma JCRB0429 KMS-12-BM myeloma, late stage of B-cell differentiation
human myeloma JCRB0430 KMS-12-PE myeloma, late stage of B-cell differentiation
human myeloma JCRB1196 KMS-20 human myeloma cell line.
human myeloma JCRB1185 KMS-21BM human myeloma cell line.
human myeloma JCRB1187 KMS-26 human myeloma cell line.
human myeloma JCRB1188 KMS-27 human myeloma cell line.
human myeloma JCRB1192 KMS-28BM human myeloma cell line.
human myeloma JCRB1191 KMS-28PE Human myeloma cell line.
human myeloma JCRB1391 KMS-33 human myeloma cell line.
human myeloma JCRB1195 KMS-34 human myeloma cell line.
human myeloma JCRB4021 KMS21 human myeloma cell line. Deposited as a set with KMS21R and KMS21RF
human myeloma JCRB1820 MOLP-2 Multiple myeloma-derived cell line. IL-6 receptor(+), CD28(+), CD33(+), IgD ramda(+) (Growth is extremely slow, DT = 1 week.)
human:nasal septum          Top
human nasal septum JCRB9058 RPMI 2650 quasi-diploid squamous carcinoma
human:neural          Top
human neural JCRB0228 A-172 glioblastoma
human neural IFO50361 B2-17 astrocytoma, thymidine kinase-deficient mutant of U-251 MG cells
human neural IFO50289 Becker astrocytoma, GFAP-negative
human neural JCRB0068 Flow3000 normal fibroblast
human neural IFO50489 GB-1 glioma, GFAP, vimentin and fibronectin-positive
human neural JCRB0612 GOTO neuroblastoma, adrenal gland
human neural JCRB9050 IMR-32 Human neuroblastoma cell line.
human neural IFO50283 IMR-32 Human nueroblastoma cell line.
human neural IFO50434 KALS-1 GFAP is weakly positive.
human neural JCRB0236 KG-1-C mixed glioma, GFAP-negative, S-100-positive (growth is very slow).
human neural IFO50435 KINGS-1 astrocytoma, anaplastic, S-100, vimentin, CD13 and HNK-1-positive, weakly GFAP positive.
human neural IFO50357 KNS-60 glioma, GFAP, S-100 and NSE-negative
human neural IFO50359 KNS-81 glioma, GFAP and S-100-positive, NSE-negative
human neural IFO50444 KNS-81-FD GFAP-positive human glioma cell line.
human neural IFO50432 KP-N-RT-BM-1 neuroblastoma, from bone marrow, neuronal and Schwannian differentiation
human neural IFO50433 KP-N-SI9s Alpha-smooth muscle actin and desmin-positive. Some S-type cells may have the potential to differentiate into cells with smooth muscle phonotypes.
human neural IFO50431 KP-N-YN Alpha smooth muscle actin-positive.
human neural IFO50436 KS-1 glioblastoma
human neural JCRB0154 NB(TU)1-10 Humn neuroblastoma(stageIII) cell line from abdominal tumor with N-myc aberration.
human neural JCRB0621 NB-1 Human neuroblastoma cell line differentiate in vitro by cAMP.
human neural IFO50295 NB-1 neuroblastoma
human neural JCRB1305 NCC-RbC-39 Huaman retinoblastoma cell line. The growth is extremely slow.
human neural JCRB1182 NCC-RbC-51 Human retinoblastoma cell line. The growth is very slow.
human neural JCRB1200 NCC-RbC-53 Human retinoblastoma cell line. The growth is extremely slow.
human neural JCRB1183 NCC-RbC-54 Human retinoblastoma cell line. The growth is extremely slow.
human neural JCRB1212 NCC-RbC-56 Human retinoblastoma cell line. The growth is extremely slow.
human neural JCRB1190 NCC-RbC-57 Human retinoblastoma cell line.
human neural JCRB1326 NCC-RbC-60 Huaman retinoblastoma cell line. The growth is very slow.
human neural JCRB1214 NCC-RbC-67 Human retinoblastoma cell line. The growth is extremely slow.
human neural JCRB1221 NCC-RbC-92 Huaman retinoblastoma cell line. The growth is extremely slow.
human neural JCRB1223 NCC-RbC-T1 Human retinoblastoma cell line. The growth is very slow.
human neural JCRB0833 NH-12 neuroblastoma, adrenal gland
human neural JCRB0832 NH-6 neuroblastoma, adrenal gland, opsomyoclonus, truncal ataxia
human neural IFO50467 NMC-G1 glioma, FGF-9-producing
human neural IFO50368 no.10 Human anaplastic glioma cell line derived from brain.
human neural IFO50369 no.11 glioma, anaplastic, GFAP-positive
human neural JCRB1566 NP 2 Human cell line derived from human glioma.
human neural JCRB1567 NP 3 Human cell line derived from human glioma.
human neural JCRB1608 NP 8 Human cell line derived from human glioma.
human neural JCRB1606 Onda 10 Human cell line derived from human glioma.
human neural JCRB1605 Onda 11 Human cell line derived from human glioma.
human neural JCRB1575 Onda 7 Human cell line derived from human glioma.
human neural JCRB1578 Onda 8 Human cell line derived from human glioma.
human neural JCRB1576 Onda 9 Human cell line derived from human glioma.
human neural JCRB1583 Onda 9R Human cell line derived from human recurred glioma.
human neural JCRB1607 Onda 9R-B12 Human clonal cell line derived from human recurred glioma.
human neural IFO50355 ONS-76 medulloblastoma
human neural JCRB1340 RS-2 metastatic primitive neuroectodermal tumor cell line (derived from metastatic tumor).
human neural JCRB0106 SCCH-26 Human neuroblastoma cell line.
human neural IFO50286 SF126 glioblastoma multiforme, GFAP-negative
human neural JCRB9041 T98G Human glioblastoma multiforma tumor.
human neural IFO50303 T98G glioblastoma, multiforme
human neural JCRB0139 TASK1 Human cell line with primitive neuroectodermal tumor (Askin's tumor).
human neural JCRB0618 TGW neuroblastoma, adrenal gland
human neural JCRB0618.1 TGW.P3 Serum free cell culture of the human neuroblastoma cell line, TGW.
human neural IFO50288 U-251 MG astrocytoma, GFAP-positive
human neural IFO50285 U-251 MG (KO) Subline of U-251 MG (IFO 50288) with epithelial morphology.
human neural IFO50493 YH-13 glioblastoma, GFAP and S-100-positive, ACNU(a cancer chemotherapy drug)-resistant
human neural JCRB0746 YKG-1 glioblastoma
human:neuroblastoma cell line          Top
human neuroblastoma cell line JCRB0612.1 GOTO.P3 Serum free cell culture of neuroblastoma cell line.
human:oral          Top
human oral JCRB0625 Ca9-22 squamous carcinoma, gingiva
human oral JCRB9095 HEPM embryonic palatal mesenchyme, limited life span
human oral JCRB0831 HO-1-N-1 squamous carcinoma, buccal mucosa
human oral JCRB1354 HSC-3-M3 Highly metastatic cell line to lymph node in human oral squamous cell carcinoma derived from the HSC-3.
human oral JCRB9103 KD fibroblast, lip
human oral JCRB0194 KON Human squamous carcinoma cell line from oral floor.
human oral JCRB0126.1 KOSC-2 cl3-43 Human tumor cells derived from oral cancer at stage III. The cells were originally cross contaminated with mouse cells but the mouse cells were eliminated in the JCRB cell bank and the cl3-43 subclone ID was applied to the cell name.
human oral JCRB0198 OSC-19 Human squamous cell carcinoma cell line from tongue tumor with serum free cell culture.
human oral JCRB0197 OSC-20 Human squamous cell carcinoma cell line from tongue metastasized to neck lymph node(left), which was cultured with serum free condition.
human oral JCRB0260 SAS squamous carcinoma, tongue
human oral JCRB1027 SAT Human squamous cell carcinoma with non-metastatic cell line derived from oral cavity.
human oral JCRB9118 SCC-4 squamous carcinoma, tongue
human oral JCRB1039 SKN-3 Human oral squamous carcinoma established from xenotransplantation in mice.
human:oral cancer          Top
human oral cancer JCRB0828 HO-1-u-1 squamous carcinoma, mouth floor
human oral cancer JCRB0622 HSC-2 squamous carcinoma, mouth
human oral cancer JCRB0624 HSC-4 Human squamous carcinoma cell line from tongue.
human:ovarian cancer          Top
human ovarian cancer JCRB1729 RMG-V Human ovarian clear cell adenocarcinoma cell line.
human:ovary          Top
human ovary JCRB1359 HAC-2 Human ovary cancer cell line derived from mesonephros.
human ovary JCRB1539 HAC-2 Human ovary cancer cell line derived from mesonephros.
human ovary JCRB0098 KURAMOCHI undifferentiated carcinoma, ascites
human ovary JCRB0240 MCAS mucinous cystadenocarcinoma
human ovary JCRB1308 NCC-OvC-K119 Huaman ovarian carcinoma cell line.
human ovary JCRB1043 OVISE Human cell line derived from ovarian tumor.
human ovary JCRB1044 OVKATE Human cell line derived from ovarian tumor.
human ovary JCRB1045 OVMANA Human cell line derived from ovarian tumour.
human ovary JCRB1049 OVMIU Human cell line derived from ovarian tumour.
human ovary JCRB1050 OVMIU-II Human cell line derived from ovarian tumour.
human ovary JCRB1046 OVSAHO Human cell line derived from ovarian tumour.
human ovary JCRB1047 OVSAYO Human cell line derived from ovarian tumour.
human ovary JCRB1048 OVTOKO Human cell line derived from ovarian tumour.
human ovary IFO50317 RKN leiomyosarcoma
human ovary JCRB0176 RKN Human tumor cell line from myoma ovarii.
human ovary IFO50315 RMG-I clear cell carcinoma
human ovary JCRB0172 RMG-I Human tumor cell line from ovarian mesonephroid adenocarcinoma.
human ovary JCRB0172.1 RMG-II Human ovarian mesonephroid adenocarcinoma cell line.
human ovary IFO50320 RMUG-S mucinous cystadenocarcinoma
human ovary JCRB0234.0 TYK-nu undifferentiated carcinoma
human ovary JCRB0234.1 TYK-nu.CP-r Human cell line derived from ovary with undifferentiated carcinoma.
human:pancreas          Top
human pancreas JCRB4026 KE-66 Poorly differentiated adenocarcinoma with giant cells
Japan Domestic use only human pancreas JCRB1427 KMP2 Human moderately differentiated pancreatic adenocarcinoma cell line established from liver metastasis.
Japan Domestic use only human pancreas JCRB1464 KMP5 Human moderately differentiated adenocarcinoma cell line established from liver metastasis.
Japan Domestic use only human pancreas JCRB1429 KMP7 Human pancreatic adenocarcinoma cell line established from liver metastasis.
Japan Domestic use only human pancreas JCRB1461 KMP8 Human moderately differentiated pancreatic adenocarcinoma cell line established from liver metastasis.
human pancreas JCRB0181 KP-2 Human pancreatic tumor cell line.
human pancreas JCRB0178.0 KP-3 A metastasis of adenosquamous carcinoma of the human pancreatic duct.
human pancreas JCRB0178.1 KP-3L Human tumor cell line obtained from metastasis of adenosquamous carcinoma of the pancreatic duct.
human pancreas JCRB0182 KP-4 Human tumor cell line secreting parathyroid hormone-related peptide (PTHrP) established from pancreatic tumor.
human pancreas JCRB0070 MIA PaCa-2 pancreatic cancer
human pancreas JCRB0183 QGP-1 Carcinoembryonic antigen (CEA)-producing human pancreatic ilet cell carcinoma cell line.
human pancreas JCRB1882 Sui65 Pancreatic adenocarcinoma. Cell line established by forming xenograft tumor (PDX) from peritoneal metastasis.
human pancreas JCRB1919 Sui69 Pancreatic adenocarcinoma. Cell line established by forming xenograft tumor (PDX) from pancreas adenocarcinoma. (The life span of this cell line is limited.)
human pancreas JCRB1931 Sui74 Pancreatic adenocarcinoma. Cell line established by forming xenograft tumor (PDX) from pancreas adenocarcinoma.
human pancreas JCRB1929 Sui77 Pancreatic adenocarcinoma. Cell line established by forming xenograft tumor (PDX) from liver metastasis.
human pancreas JCRB1094 SUIT-2 Human pancreatic cancer cell line established from liver metastasis.
human pancreas JCRB1921 TCC-Pan2 Pancreatic ductal adenocarcinoma. Cell line established from ascites.
Japan Domestic use only human pancreas JCRB1500 TYPK-1 Human pancreas adenocarcinoma cell line.
human:placenta          Top
human placenta JCRB9111 BeWo Human placenta derived cell line.
human:pleura          Top
human pleura JCRB1913 Me1Tu Transplanted cell line of malignant pleural mesothelioma TCC-MESO-1 into SCID mice.
human pleura JCRB1930 Me2Tu Transplanted cell line of malignant pleural mesothelioma TCC-MESO-2 into SCID mice.
human pleura JCRB1937 Me3Tu Transplanted cell line of malignant pleural mesothelioma TCC-MESO-3 into SCID mice.
human pleura JCRB1894 TCC-MESO-1 Cell line of malignant pleural mesothelioma. TCC-MESO-2 established from same individual.
human pleura JCRB1898 TCC-MESO-2 Cell line of malignant pleural mesothelioma. TCC-MESO-1 established from same individual.
human pleura JCRB1909 TCC-MESO-3 Cell line of malignant pleural mesothelioma.
human:prostate gland          Top
human prostate gland JCRB9110 PC-3 adenocarcinoma
human:rectum          Top
human rectum JCRB0207 CaR-1 adenocarcinoma
human rectum JCRB0256 RCM-1 adenocarcinoma, well differentiated
human rectum JCRB9115 SW837 adenocarcinoma
human rectum JCRB1986 UCCA-24 Derived from colorectal cancer with ulcerative colitis. Isolated as poorly differentiated adenocarcinoma by cloning.
human rectum JCRB1997 UCCA-25 Derived from colorectal cancer with ulcerative colitis. Isolated as adenosquamous carcinoma of the adenomas by cloning.
human:sarcoma          Top
human sarcoma IFO50107 G-292 clone A141B1 osteosarcoma
human sarcoma IFO50106 HOS osteosarcoma
human sarcoma JCRB9113 HT-1080 Human sarcoma cell line with activated N-ras oncogne.
human sarcoma IFO50354 HT-1080 fibrosarcoma, acetabulum
human sarcoma JCRB0413 HuO-3N1 osteosarcoma, ilium
human sarcoma JCRB0427 HuO9 A cell line established from a human osteosarcoma transplanted into athymic nude mice after fifth passages. The cell line expressed 1,25(OH)2D3-responsive alikaline phosphatase and produced tumors in the dorsum of nude mice.
human sarcoma JCRB0428 HuO9N2 osteosarcoma
human sarcoma JCRB1648 ICH-ERMS-1 Human cell derived from anaplastic embryonal rhabdomyosarcoma.
human sarcoma JCRB0200 KMLS-1 liposarcoma
human sarcoma JCRB0627 KYM-1 Human rhabdomyosarcoma cell line derived from neck tumor.
human sarcoma IFO50108 MG-63 osteosarcoma
Japan Domestic use only human sarcoma JCRB1507 NMFH-1 Human retroperitoneal tumor cell line.
human sarcoma JCRB0614 NY osteosarcoma, femur
human sarcoma IFO50488 OUMS-27 chondrosarcoma, type 1 ,2 and 3 collagens; type 9 and 11 collagen mRNA; proteoglycan-producing
human sarcoma JCRB1806 PIS-1 Human pulmonary intimal sarcoma
human sarcoma JCRB9072 RD rhabdomyosarcoma
human sarcoma JCRB0108 SCCH-196 Human small round cell sarcoma.
Japan Domestic use only human sarcoma JCRB1521 TYLMS-1 Human leiomyosarcoma cell lineestablised from retroperitopneal tumor.
human:skin          Top
human skin IFO50418 ASF-4-1 Normal diploid (46, XY) fibroblast with limited life span. The ASF-4-1 and the ASF-4-2 lines were established from skins of the same donor at different ages. This cell line was taken from the donor at 36 years and 2 month-old
human skin IFO50419 ASF-4-2 Normal diploid (46, XY) fibroblast with limited life span. The ASF-4-1 and ASF-4-2 lines were established from skins of the same donor at different ages. This cell line was taken from the donor at 47 years and 6 month-old.
human skin JCRB1431 ASF-4-3L Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3 and the ASF-4-4 lines were established from skins of the same donor at different ages.
human skin JCRB1441 ASF-4-4L1 Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3 and the ASF-4-4 lines were established from skins of the same donor at different ages.
human skin JCRB1442 ASF-4-4L2 Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3 and the ASF-4-4 lines were established from skins of the same donor at different ages.
human skin JCRB1705 ASF-4-5L1 Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3, ASF-4-4 and the ASF-4-5 lines were established from skins of the same donor at different ages.
human skin JCRB1703 ASF-4-5L2 Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3, ASF-4-4 and the ASF-4-5 lines were established from skins of the same donor at different ages.
human skin JCRB1709 ASF-4-5R1 Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3, ASF-4-4 and the ASF-4-5 lines were established from skins of the same donor at different ages.
human skin JCRB9078 De Gin osteoporosis, skin
human skin JCRB9104 Detroit 510 Human skin, galactosemia cell line.
human skin JCRB9102 Detroit 525 Turner's syndrome, skin
human skin JCRB9044 Detroit 532 Fibroblast line from Down's syndrome patient.
human skin JCRB9045 Detroit 539 Down's syndrome, skin
human skin IFO50079 Flow7000 Normal diploid fibroblasts with limited life span.
human skin JCRB1008 HFb16d Normal human fibroblast cell line derived from foreskin which was transfected by the HPV16 DNA. No teromerase activity.
human skin JCRB1017 HKA-1 A cell line derived from a keratoacanthoma of human skin, grow in a monolayer with anaplastic feature.
human skin IFO50350 Hs68 Normal diploid fibroblasts with limited life span.
human skin JCRB1015 HSC-1 A cell line of a squamous cell carcinoma of human skin.
human skin JCRB1016 HSC-5 A cell line derived from human skin squamous cell carcinoma having anaplastic epithelioid features.
human skin JCRB0072 MiTen Human cell line from Lesch-Nyhan syndrome.
human skin JCRB0141 PHK16-0b Normal keratinocyte cells immortalized with HPV16 virus genome and the growth is dependent to EGF. More than 95% of cells are diploid.
human skin JCRB1093 PSVK1 Human normal keratinocyte prepared from human foreskin that was immortalized by the infection of the pSV40 ori-(minus) DNA.
human skin JCRB9079 Ran Nor osteoporosis, skin
human skin JCRB0075 SF-TY normal fibroblast
human skin JCRB0526 TIG-101 Normal human diploid cell from skin
human skin JCRB0527 TIG-102 Normal human skin fibroblast cell line.
human skin JCRB0528 TIG-103 skin, normal diploid fibroblast
human skin JCRB0532 TIG-107 skin, normal diploid fibroblast
human skin JCRB0537 TIG-108 skin, normal diploid fibroblast
human skin JCRB0538 TIG-109 Normal diploid human skin cells.
human skin JCRB0543 TIG-110 Normal diploid fibroblast from human skin with limited lifespan.
human skin JCRB0541 TIG-111 Normal diploid fibroblast from human skin with limited lifespan.
human skin JCRB0533 TIG-112 skin, normal diploid fibroblast
human skin JCRB0539 TIG-113 Human normal fibroblast from skin.
human skin JCRB0534 TIG-114 skin, normal diploid fibroblast
human skin JCRB0535 TIG-118 skin, normal diploid fibroblast
human skin JCRB0540 TIG-119 Normal human diploid cell from skin.
human skin JCRB0542 TIG-120 Normal diploid fibroblast from human skin with limited lifespan.
human skin JCRB0536 TIG-121 skin, normal diploid fibroblast
human skin JCRB0544 TIG-3S Normal diploid fibroblast from human male skin with limited life span.
human:stomach          Top
human stomach JCRB1886 39As8 Peritoneal disseminated metastatic cell line established from signet ring cell gastric carcinoma (HSC-39).
human stomach JCRB1950 85As2 Peritoneal disseminated metastatic cell line established from gastric cancer cell line (MKN45cL85). Cachexia-inducing cell line.
human stomach JCRB0061 AZ-521 Reported as Human gastric cancer cell line. The STR DNA analysis pattern of AZ-521 revealed to be identical to that of other cell line derived from human duodenum carcinoma, HuTu 80 in ATCC (registry number, HTB-40)
human stomach JCRB1074 FU97 Human stomach cancer cell line with AFP production.
human stomach JCRB1956 HSC-39 PF Cell line that can be cultured only with HamF12/DMEM (protein free). Culture start at thawing must with 2% FBS.
human stomach JCRB1954 HSC-39R10C HSC-39-derivative. TGF-β resistant subclone mutated by MNU (N-Methyl-N-nitrosourea).
human stomach JCRB1075.0 IM95 Human gastric cancer cell line.
human stomach JCRB1075.1 IM95m Human gastric cancer cell line.
human stomach JCRB0611 KATOIII signet ring cell carcinoma
Human:stomach          Top
Human stomach JCRB1939 MKN45cL85 Subclone of MKN45 (Human Gastric Cancer) cell line. Cachexia-inducing cell line.
human stomach JCRB1025 MKN7 tubular adenocarcinoma, well differentiated
human stomach JCRB0255 MKN74 Human cell line derived from stomach cancer.
human stomach JCRB1228 NCC-StC-K140 Human stomach carcinoma cell line.
human stomach JCRB0821 NUGC-2 adenocarcinoma, poorly differentiated
human stomach JCRB0822 NUGC-3 adenocarcinoma, poorly differentiated
human stomach JCRB0834 NUGC-4 adenocarcinoma, poorly differentiated, signet ring cell carcinoma
human stomach JCRB0192 OCUM-1 Human gastric cancer cell line from poorly differentiated adenocarcinoma.
human stomach JCRB1009 RERF-GC-1B Human gastric cancer cell line established from a metastatic tissue of pyloric lymph nodes.
human stomach JCRB0251 SCH choriocarcinoma arising at stomach from male patient
human stomach JCRB1944 SH101-P4 Subclone of SH101 (Human Gastric Cancer) cell line. Well differenciated adenocarcinoma.
human stomach JCRB0124 Takigawa gastric carcinoma, proliferates very slowly (D.T.=2 weeks).
human stomach JCRB1941 TU-KatoIII Cell line isolated as 100% tumor-forming cells after tumor formation in immunodeficient mice (NOD Scid→Scid→nu/nu).
Japan Domestic use only human stomach JCRB1522 YS-1 Human primmary cell line established from stomach (tumor infiltrating fibroblast).
human:stomach cancer          Top
human stomach cancer JCRB1864 HSC-39 Human signet ring cell gastric carcinoma cell line establised in vitro from ascites.
human stomach cancer JCRB0252 MKN1 adenosquamous carcinoma
human stomach cancer JCRB0254 MKN45 adenocarcinoma, poorly differentiated
human:teratocarcinoma          Top
human teratocarcinoma JCRB1005 NCC-IT-A3 Human teratocarcinoma cell line from anterior mediastinum.
human teratocarcinoma JCRB9061 PA-1 Human ovarian teratocarcinoma.
human teratocarcinoma JCRB1052 PA-1/6TG-r Human teratocarcinoma cell line PA-1 with 6TG resistance.
human:testis          Top
human testis JCRB0613 ITO-II Human testicular tumor cell line.
human testis JCRB1166 NCR-G1 Human yolk sac tumor (testicular tumor)
human testis JCRB1167 NCR-G2 Complex type germ cell tumor of human testis origin.
human testis JCRB1168 NCR-G3 Complex type germ cell tumor of human testis origin.
human testis JCRB1175 NCR-G4 Complex type germ cell tumor of human testis origin.
human testis JCRB0162 NEC14 testicular germ cell tumor
human testis JCRB0250 NEC8 testicular germ cell tumor
human:thymus          Top
human thymus JCRB1330 Ty-82 Thymic carcinoma cell line.
human:thyroid          Top
human thyroid JCRB0824 8305C Human undifferentiated thyroid carcinoma with C:G->T:A mutation at codon 273 of p53 gene.
human thyroid JCRB0826 8505C thyroid carcinoma, undifferentiated
human thyroid JCRB1073 ASH-3 Tumor cell line with multidrug registance obtained from rapidly growing cervical tumor(neck) diagnosed as an anaplastic thyroid carcinoma.
human thyroid JCRB0164 HTC/C3 Human thyroid carcinoma cell line.
human thyroid JCRB1079 IHH-4 Human papillary thyroid carcinoma cell line metastased to lymphnode. STR-PCR analysis showed the same pattern with the cell line TMH-1.
human thyroid JCRB0148 KHM-5M Undifferentiated human thyroid cell line producing interl eukin 8.
human thyroid JCRB1066 KMH-2 Human anaplasitc thyroid carcinoma cell line with multidrug resistance, derived from a left cervical tumor with a sligt leukocytosis.
human thyroid JCRB1891 OCUT-1C human anaplastic thyroid cancer cell line
human thyroid JCRB1892 OCUT-3 human anaplastic thyroid cancer cell line
human thyroid JCRB0239 TCO-1 non differentiated cancer
human thyroid JCRB1078 TMH-1 Human adherent monolayer cell line with multidrug resistance obtained from a benign goiter and chronic thyroiditis.
human:thyroid cancer          Top
human thyroid cancer JCRB1897 OCUT-1F human anaplastic thyroid cancer cell line
human thyroid cancer JCRB1857 OCUT-4 human anaplastic thyroid cancer cell line
human thyroid cancer JCRB1872 OCUT-6 human anaplastic thyroid cancer cell line
human:tongue          Top
human tongue JCRB0623 HSC-3 Human oral squamous carcinoma cell line with high metastatic potential.
human:uterine cervix          Top
human uterine cervix IFO50323 BOKU cervical squamous cell carcinoma
human uterine cervix IFO50007 Ca Ski Human epidermoid cervical cancer cell line.
human uterine cervix JCRB1153 HCA-1 Human endocervical adenocarcinoma cell line.
human uterine cervix JCRB1203 HCS-2 Human squamous cell carcinoma from uterine cervix.
human uterine cervix JCRB1205 HCSC-1 Human endocervical carcinoma cell line.
human uterine cervix JCRB9004 HeLa The first aneuploid, epitherial-like cell line(Feb. 1951) from human tissue and maintained continuously by serial cell culture.
human uterine cervix JCRB9086 HeLa 229 Subline of the HeLa cell.
human uterine cervix JCRB0213 HeLa AG epitheloid carcinoma, 8-azaguanine-resistant
human uterine cervix JCRB9010 HeLa S3 cervical epitheloid carcinoma, adaptable to a suspension culture
human uterine cervix IFO50011 HeLa S3 This cell line is a clone derived from the HeLa cells. Adaptable to suspension culture.
human uterine cervix JCRB0713 HeLa S3 (sc) HeLa derivative, can grow in suspension culture
human uterine cervix JCRB0214 HeLa TG epitheloid carcinoma, 6-thioguanine-resistant
human uterine cervix JCRB0215 HeLa TG Cap epitheloid carcinoma, 6-thioguanine, chloramphenicol-resistant
human uterine cervix JCRB0649 HeLa.P3 Serum free cell line of the famous HeLa.
human uterine cervix JCRB0606 HeLa.P3(S) HeLa cell derived, can grow in a serum-free medium
human uterine cervix JCRB0810 ME-180 cervical carcinoama
human uterine cervix JCRB0174.0 NCC16-P11 Normal human endo-cervical columner cells immortalized by HPV16 virus genome and no tumor formation observed in nude mice. Growth is not dependent to EGF.
human uterine cervix JCRB1090 NCE 16IIA HPV16 transformed noraml cells derived from human cervix.
human uterine cervix JCRB1092 NCE SVIA6 SV40 transformed human keratinocyte cell line.
human uterine cervix JCRB1091 NCE SVIIA3 SV40 transformed keratinocyte cells derived from human cervix.
human uterine cervix JCRB0140 NCE16 Normal ecto-cervical keratinocyte cells immortalized by HPV16 virus genome. Growth of this cell line is dependent to EGF.
human uterine cervix IFO50308 SKG-I cervical epidermoid carcinoma
human uterine cervix IFO50309 SKG-II cervical epidermoid carcinoma, large cell, non-keratinizing type
human uterine cervix JCRB0232 SKG-IIIa cervical epidermoid carcinoma, clear cell type
human uterine cervix IFO50310 SKG-IIIa cervical epidermoid carcinoma, clear cell type
human uterine cervix IFO50311 SKG-IIIb cervical epidermoid carcinoma, large cell, non-keratinizing type
human uterine cervix JCRB0232.1 SKG-IIIb Human tumor cell line with non-keratinizing type squamous cell carcinoma from cervical tumor. Temperature sensitive growth was observed.
human:uterus          Top
human uterus JCRB1601 EMTOKA Human cell line derived from uterine carcinosarcoma.
human uterus JCRB1201 GCH-nu-YS Human gestational choriocarcinoma cell line.
human uterus JCRB0042 HEC-1 Human endometrial adenocarcimona cell line. (HEC-1-B).
human uterus JCRB1117 HEC-1-A Human endometroid adenocarcinoma, G2 from Japanese female.
human uterus JCRB1193 HEC-1-B Endometrioid adenocarcinoma (G2) from human uterus body.
human uterus JCRB1123 HEC-108 Human tumor cell line from uterine endometrium.
human uterus JCRB1124 HEC-116 Human tumor cell line from endometrioid adenocarcinoma G2.
human uterus JCRB1122 HEC-151 Human endometrioid adenocarcinoma, G2.
human uterus JCRB1141 HEC-251 Human endometrial carcinoma from uterus body.
human uterus JCRB1142 HEC-265 Human endometrioid adenocarcinoma, G1 from uterus.
human uterus JCRB1145 HEC-50B Human endometrioid adenocarcinoma (G3) from japanese patient.
human uterus JCRB1120 HEC-59 Human tumor cell line from endometrioid adenocarcinoma G2.
human uterus JCRB1118 HEC-6 Human endometrial adenocarcinoma cell line.
human uterus JCRB1121 HEC-88nu endometrial adenocarcinoma
human uterus IFO50322 NJG gestational uterine choriocarcinoma
human uterus IFO50314 SKN leiomyosarcoma
human uterus IFO50312 SNG-II endometrial adenocarcinoma
human uterus IFO50313 SNG-M endometrial adenocarcinoma
human uterus JCRB0179 SNG-M Intermedicately differentiated human adenocarcinoma cell line.
human:uterus cancer          Top
human uterus cancer JCRB1505 Ishikawa 3-H-12 Estrogen receptor (ER), progesterone receptor (PR) expressing cell line.
human uterus cancer JCRB0173 SKN Human tumor cell line from uterus leiomyosarcoma.
human:vascular system          Top
human vascular system IFO50271 HUV-EC-C Normal endothelial cells with limited life span. For cultivation, endothelial cell growth supplement can be substituted by ca 10 ng/ml basic FGF.
Japan Domestic use only human vascular system JCRB1520 TYHPC-1 Human hemangiopericytoma cell line established from liver metastasis.
human chromosome-introduced:human monochromosomal hybrid panel          Top
human chromosome-introduced human monochromosomal hybrid panel JCRB2209 CHO(His9) contains human chromosome # 9 (MTA with Tottori Univ. is required.)
Indian Muntjak:skin          Top
Indian Muntjak skin JCRB9100 Indian Muntjac Indian muntjak cell line, a primitive deer.
Indian Muntjak:thymus          Top
Indian Muntjak thymus JCRB0609.1 Mm2T.P3 Mutntjac thymus cell cell line.
Indian Muntjak thymus JCRB0650.1 Mm2T12.P3 Serum free subline from Mm2T cells.
marsupial (potoroo, rat kangaroo):kidney          Top
marsupial (potoroo, rat kangaroo) kidney JCRB9039 Pt K1 kidney
marsupial (potoroo, rat kangaroo) kidney JCRB0007 Pt K2 DNA replication study
marsupial (potoroo, rat kangaroo) kidney IFO50012 Pt K2 kidney, epithelial-like
marsupial (potoroo, rat kangaroo) kidney JCRB9052 Pt K2 (NBL-5) kidney
mink:lung          Top
mink lung JCRB9128 Mv 1 Lu useful for focus forming assays of murine and feline sarcoma virus
monkey, African green:kidney          Top
Japan Domestic use only monkey, African green kidney JCRB9126 BS-C-1 Kidney cell line of the african green monkey.
Japan Domestic use only monkey, African green kidney IFO50413 BS-C-1 suitable host for transfection experiments of SV40 vectors
Japan Domestic use only monkey, African green kidney JCRB9082 COS-1 SV40 transformed African green monkey kidney
Japan Domestic use only monkey, African green kidney JCRB9127 COS-7 African green monkey cell line producing T antigen of SV40.
Japan Domestic use only monkey, African green kidney IFO50068 COS-7 This line is a transformant derived from CV-1 cell by origin gene-defective mutant of SV40 virus. This cell line is useful for transfection of expression plasmid.
Japan Domestic use only monkey, African green kidney JCRB9049 CV-1 kidney, highly susceptible to SV40 infection
Japan Domestic use only monkey, African green kidney JCRB0111 VERO African Green Monkey kidney normal cell line.
Japan Domestic use only monkey, African green kidney JCRB9013 VERO normal, contact inhibited
Japan Domestic use only monkey, African green kidney IFO50471 Vero useful to assay mycoplasmas
Japan Domestic use only monkey, African green kidney JCRB9007 VERO 76 normal, contact inhibited, lower saturation density than the original Vero
Japan Domestic use only monkey, African green kidney IFO50410 VERO 76 Subclone of the VERO cells.
monkey, Cynomolgus:hemo-lymphocytic          Top
Japan Domestic use only monkey, Cynomolgus hemo-lymphocytic JCRB1646 HSC-3 Peripheral blood lymphocyte cell line of cynomolgus monkey (immortalized by Herpesvirus saimiri).
Japan Domestic use only monkey, Cynomolgus hemo-lymphocytic JCRB1652 HSC-4 Peripheral blood lymphocyte cell line of cynomolgus monkey (immortalized by Herpesvirus saimiri).
Japan Domestic use only monkey, Cynomolgus hemo-lymphocytic JCRB1164 HSC-F T-cell line (fetal spleen-derived lymphocytes) of cynomolgus monkey.
monkey, Cynomolgus:kidney          Top
Japan Domestic use only monkey, Cynomolgus kidney JCRB0607.1 MK.P3 Serum free cell culture of the MK(monkey kidney, JTC-12) cell.
Japan Domestic use only monkey, Cynomolgus kidney JCRB0607 MK.P3(F) other name is JTC-12.P3(F)
monkey, rhesus:hemo-lymphocytic          Top
Japan Domestic use only monkey, rhesus hemo-lymphocytic JCRB1644 HSR-1 Peripheral blood lymphocyte cell line of rhesus monkey (immortalized by Herpesvirus saimiri).
Japan Domestic use only monkey, rhesus hemo-lymphocytic JCRB1641 HSR-4 Peripheral blood lymphocyte cell line of rhesus monkey (immortalized by Herpesvirus saimiri).
mosquito:hatched larvae          Top
mosquito hatched larvae IFO50010 C6/36 This cell line is useful for replication of flavoviruses and dengue virus.
mouse:          Top
mouse JCRB1621 hTf2-9F/sf This cell line produce monoclonal antibody against human transferrin.
mouse JCRB1632 VV-1H831 Mouse hybridoma producing mAb (IgG1) to hemagglutinine (HA) of vaccinia virus.
mouse:adrenal cortex          Top
mouse adrenal cortex JCRB9056 Y-1 adrenocortical tumor, steroid-secreting, (LAF1 mouse)
mouse:antibody-producing hybridoma          Top
mouse antibody-producing hybridoma JCRB0013 16-8 Mouse hybridoma cell line producing monoclonal antibody to human erythrocyte.
mouse antibody-producing hybridoma JCRB0014 19-7 Mouse hybridoma cell line producing monoclonal antibody to human erythrocyte.
mouse antibody-producing hybridoma JCRB0084 4-2D anti-primase complexed with DNA polymerase alpha
mouse antibody-producing hybridoma JCRB0083 4-8H anti-DNA polymerase alpha, IgG1
mouse antibody-producing hybridoma IFO50284 A2B5 clone 105 Produces anti-chick retinal neuron glycolipid monoclonal antibody (IgM class).
mouse antibody-producing hybridoma JCRB1392 AS17 Hybridoma cell line producing antibody against human annexin IV.
mouse antibody-producing hybridoma JCRB1213.3 DIG104.10H.1 Mouse hybridoma cell line producing monoclonal antibody against digoxin.
mouse antibody-producing hybridoma JCRB1213.2 DIG222.4D.5 Mouse hybridoma cell line producing monoclonal antibody against digoxin.
mouse antibody-producing hybridoma JCRB1324 F119 Mouse hybridoma cell line producing F119 MAb against CD307(IRTA2/FcRH5/FCRL5).
mouse antibody-producing hybridoma JCRB1323 F25 Mouse hybridoma cell line producing F25 MAb against CD307 (IRTA2/FcRH5/FCRL5).
mouse antibody-producing hybridoma JCRB1189 F56 Mouse hybridoma cell line producing F56 MAb against CD307(IRTA2/FcRH5/FCRL5).
mouse antibody-producing hybridoma JCRB1226 GHBP116 Mouse hybridoma cell line producing monoclonal antibody against human growth hormone receptor (GHBP116).
mouse antibody-producing hybridoma JCRB1381 HBs128 Mouse hybridoma cell line producing monoclonal antibody against HBs antigen.
mouse antibody-producing hybridoma JCRB1380 HBs320 Mouse hybridoma cell line producing monoclonal antibody against HBs antigen.
mouse antibody-producing hybridoma JCRB1222.01 HGH1.1.3 Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
mouse antibody-producing hybridoma JCRB1222.08 HGH1.11.1 Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
mouse antibody-producing hybridoma JCRB1222.09 HGH1.15.3 Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
mouse antibody-producing hybridoma JCRB1222.03 HGH1.17.2 Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
mouse antibody-producing hybridoma JCRB1222.12 HGH1.31.3 Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
mouse antibody-producing hybridoma JCRB1222.13 HGH1.32.4 Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
mouse antibody-producing hybridoma JCRB1222.04 HGH1.35.2 Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
mouse antibody-producing hybridoma JCRB1222.14 HGH1.37.3 Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
mouse antibody-producing hybridoma JCRB1222.10 HGH1.41.1 Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
mouse antibody-producing hybridoma JCRB1222.11 HGH1.46.1 Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
mouse antibody-producing hybridoma JCRB1222.02 HGH1.6.5 Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
mouse antibody-producing hybridoma JCRB1222.07 HGH1.8.1 Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
mouse antibody-producing hybridoma JCRB1222.06 HGH1.9.3 Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
mouse antibody-producing hybridoma JCRB1222.15 HGH2.4.2 Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
mouse antibody-producing hybridoma JCRB1222.05 HGH2.6.1 Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH).
mouse antibody-producing hybridoma JCRB1314 HPSV178-4-3 Hybridoma cell line producing mAb HPSV178, against the C-terminal portion of PrPSV (residues 214-230).
mouse antibody-producing hybridoma JCRB1603 hTf18-10C This cell line produce monoclonal antibody against human transferrin.
mouse antibody-producing hybridoma JCRB1611 hTf18-10C/sf This cell line produce monoclonal antibody against human transferrin.
mouse antibody-producing hybridoma JCRB1504 hTf2-9F This cell line produces monoclonal antibody against human transferrin.
mouse antibody-producing hybridoma JCRB1613 hTf26-9B This cell line produce monoclonal antibody against human transferrin.
mouse antibody-producing hybridoma JCRB1599 hTf30-8H This cell line produce monoclonal antibody against human transferrin.
mouse antibody-producing hybridoma JCRB1602 hTf30-8H/sf This cell line produce monoclonal antibody against human transferrin.
mouse antibody-producing hybridoma JCRB1617 hTf9-11E This cell line produce monoclonal antibody against human transferrin.
mouse antibody-producing hybridoma JCRB0090 MB86 anti-Igh6-4 antibody-producing, IgM, (BALB/c mouse)
mouse antibody-producing hybridoma JCRB1342.06 MOR115.1.13 Mouse hybridoma cell line producing monoclonal antibody against morphine.
mouse antibody-producing hybridoma JCRB1342.07 MOR124.2.2 Mouse hybridoma cell line producing monoclonal antibody against morphine.
mouse antibody-producing hybridoma JCRB1342.08 MOR131.5.13 Mouse hybridoma cell line producing monoclonal antibody against morphine.
mouse antibody-producing hybridoma JCRB1342.09 MOR158.1.3 Mouse hybridoma cell line producing monoclonal antibody against morphine.
mouse antibody-producing hybridoma JCRB1342.11 MOR180.2.4 Mouse hybridoma cell line producing monoclonal antibody against morphine.
mouse antibody-producing hybridoma JCRB1342.10 MOR33.2.9 Mouse hybridoma cell line producing monoclonal antibody against morphine.
mouse antibody-producing hybridoma JCRB1342.02 MOR35.4.12 Mouse hybridoma cell line producing monoclonal antibody against morphine.
mouse antibody-producing hybridoma JCRB1342.03 MOR39.3.9 Mouse hybridoma cell line producing monoclonal antibody against morphine.
mouse antibody-producing hybridoma JCRB1342.12 MOR44.4.1 Mouse hybridoma cell line producing monoclonal antibody against morphine.
mouse antibody-producing hybridoma JCRB1342.04 MOR76.7F.16 Mouse hybridoma cell line producing monoclonal antibody against morphine.
mouse antibody-producing hybridoma JCRB1342.01 MOR8.2.1 Mouse hybridoma cell line producing monoclonal antibody against morphine.
mouse antibody-producing hybridoma JCRB1342.05 MOR83.3.10 Mouse hybridoma cell line producing monoclonal antibody against morphine.
mouse antibody-producing hybridoma JCRB1304 MT-45-5-3 Mouse hybridoma cell line producing monoclonal antibody against metallothionein.
mouse antibody-producing hybridoma IFO50279 NKY113 SP21/0-Ag14 myeloma x spleen from mouse immunized with a human colon adenocarcinoma SW1116. This cell line produces MSW113 monoclonal antibody. MSW113 monoclonal antibody recognizes a cancer associated antigenm sialyl-Le^a oligosaccharide.
mouse antibody-producing hybridoma JCRB1316.2 OHP101.B11.1 Mouse hybridoma cell line producing monoclonal antibody against 17alpha-hydroxyprogesterone.
mouse antibody-producing hybridoma JCRB1316.3 OHP138.H8.1 Mouse hybridoma cell line producing monoclonal antibody against 17alpha-hydroxyprogesterone.
mouse antibody-producing hybridoma JCRB1316.4 OHP1E9.3.1 Mouse hybridoma cell line producing monoclonal antibody against 17alpha-hydroxyprogesterone.
mouse antibody-producing hybridoma JCRB1316.1 OHP57.G6.1 Mouse hybridoma cell line producing monoclonal antibody against 17alpha-hydroxyprogesterone.
mouse antibody-producing hybridoma JCRB1316.6 OHP7D7.2.3 Mouse hybridoma cell line producing monoclonal antibody against 17alpha-hydroxyprogesterone.
mouse antibody-producing hybridoma IFO50466 RC1 This cell line produces a monoclonal antibody RC1 (IgG class). Immunochistochemically, RC1 antibody reacts with radial glia and neural progenitor cells in CNS.
mouse antibody-producing hybridoma JCRB0195 RP-1 Mouse cell line producing IgG1 against rat neutrophil.
mouse antibody-producing hybridoma JCRB0196 RP-3 Mouse cell line producing IgM antibody against rat neutrophil. The antibody is harmfull to the rat neutrophil in vivo or in vitro with complement.
mouse antibody-producing hybridoma JCRB0011 S.CET.M8.1.1 Mouse hybridoma cell line releasing monoclonal anti-11-deoxycortisol antibody.
mouse antibody-producing hybridoma JCRB1301 SC78.H81.C81.A9 Mouse hybridoma cell line producing monoclonal antibody against scopolamine.
mouse antibody-producing hybridoma JCRB9032 SJK-237-71 anti-DNA polymerase alpha, IgG1
mouse antibody-producing hybridoma JCRB1358.04 SRBC-F12-1-19 Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs).
mouse antibody-producing hybridoma JCRB1358.05 SRBC-F12-18-7 Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs).
mouse antibody-producing hybridoma JCRB1358.06 SRBC-F23-20-22 Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs).
mouse antibody-producing hybridoma JCRB1358.08 SRBC-F31-19-1 Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs).
mouse antibody-producing hybridoma JCRB1358.07 SRBC-F31-2-11 Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs).
mouse antibody-producing hybridoma JCRB1358.01 SRBC-P13-7-3 Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs).
mouse antibody-producing hybridoma JCRB1358.02 SRBC-P18-3-8 Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs).
mouse antibody-producing hybridoma JCRB1358.03 SRBC-P20-13-13 Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs).
mouse antibody-producing hybridoma JCRB1358.11 SRBC-RF29-1-3 Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs).
mouse antibody-producing hybridoma JCRB1358.10 SRBC-RP8-18-15 Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs).
mouse antibody-producing hybridoma JCRB1358.09 SRBC-RP8-2-4 Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs).
mouse antibody-producing hybridoma JCRB9033 STK1 anti-DNA polymerase alpha, IgG1
mouse antibody-producing hybridoma JCRB1311 ZEN Mouse hybridoma cell line producing monoclonal antibody against zearalenone.
mouse:ascites          Top
mouse ascites JCRB9090 Ehrlich ascites Ehrlich-Lettre ascites carcinoma
mouse ascites JCRB0424 JTC-11 In vitro adapted strain of Ehrlich ascites carcinoma.
mouse:bladder          Top
mouse bladder IFO50041 MBT2 bladder carcinoma
mouse:bone marrow          Top
mouse bone marrow JCRB1181 9-15c Mouse C3H/He cell line.
mouse bone marrow JCRB1548 H-1A(H123) Mouse bone marrow-derived osteoblast-like cell line.
mouse bone marrow JCRB1570 H-1D(H162) Mouse bone marrow-derived osteoblast-like cell line.
mouse bone marrow JCRB1176 KUM10 Osteoblast cell line from mouse C57/B6 bone marrow.
mouse bone marrow JCRB1134 KUM3 Osteoblast cell line from Mouse C3H bone marrow.
mouse bone marrow JCRB1135 KUM4 Osteoblastic cell line of mouse C3H.
mouse bone marrow JCRB1178 KUM5 Osteoblastic cell line of mouse C3H.
mouse bone marrow JCRB1202 KUM6 Osteoblastic cell line
mouse bone marrow JCRB1204 KUM7 Osteoblastic cell line
mouse bone marrow JCRB1139 KUM9 Osteoblastic cell line of mouse C3H.
mouse bone marrow JCRB1132 KUSA-0 Mouse osteoblastic cell line.
mouse bone marrow JCRB1119 KUSA-A1 Mouse osteoblastic cell line.
mouse bone marrow JCRB1129 KUSA-H1 mouse osteoblastic cell line
mouse bone marrow JCRB1138 NRG Osteoblastic cell line of mouse C3H.
mouse:embryo          Top
mouse embryo JCRB1355 1-1ras1000 The ras-transformed BALB/c 3T3 A31-1-1variant cell lines were strongly tumorinenic, but the cells were not metastatic. (Strain problem was found. Refer Important Notice at cell detail page.)
mouse embryo JCRB1357 1-1src The src-transformed BALB/c 3T3 A31-1-1 variant cell lines were strongly tumorinenic and metastatic.(Strain problem was found. Refer Important Notice at cell detail page.)
mouse embryo JCRB9014 3T3 L1 Clonal subline of the mouse 3T3 that accumulate large amounts of triglyceride fat when the cells are in the resting state.
mouse embryo IFO50416 3T3-L1 3T3 L1 cell line is a substrain of 3T3-Swiss albino cell line. 3T3 L1 cells convert adipose-like cells at confluent.
mouse embryo JCRB9019 3T3-Swiss albino fibroblast, contact inhibited, (Swiss albino mouse)
mouse embryo IFO50417 3T3-Swiss albino fibroblast, contact inhibited, (Swiss albino mouse)
mouse embryo JCRB9059 3T6-Swiss albino fibroblast, collagen-secreting, (Swiss albino mouse)
mouse embryo JCRB1356 A31-1-1 fibroblast, subclone of Balb/3T3-A31-1, (Strain problem was found. Refer Important Notice at cell detail page.)
mouse embryo IFO50021 A31-714 C4 fibroblast, subclone of Balb/3T3 A31, (BALB/c mouse)
mouse embryo JCRB0601 BALB/3T3 A31-1-1 fibroblast, contact inhibited, (Strain problem was found. Refer Important Notice at cell detail page.)
mouse embryo JCRB9005 BALB/3T3 clone A31 fibroblast, contact inhibited, (BALB/c mouse)
mouse embryo IFO50070 Balb/3T3-A31-1-1 fibroblast, subclone of Balb/3T3-A31-1, (Strain problem was found. Refer Important Notice at cell detail page.)
mouse embryo IFO50299 Balb/c 3T3 A31-1-13 fibroblast, subclone of Balb/3T3-A31-1, (Strain problem was found. Refer Important Notice at cell detail page.)
mouse embryo IFO50298 Balb/c 3T3 A31-I-1 fibroblast, subclone of Balb/3T3-A31-1, (Strain problem was found. Refer Important Notice at cell detail page.)
mouse embryo JCRB0149 Bhas 42 BALB 3T3 A31-1-1 cell line transfected with H-ras gene. The cell line keeps characteristics of the contact inhibition and the transfomation is induced by phorbol ester alone. No initialization required. (Strain problem was found. Refer Important Notice at cell detail page.)
mouse embryo JCRB9080 C3H/10T1/2 clone 8 fibroblast, contact inhibited, (C3H mouse)
mouse embryo JCRB0003 C3H/10T1/2-clone 8 fibroblast, contact inhibited, (C3H mouse)
mouse embryo IFO50415 C3H/10T1/2-clone8 This cell line is useful for transformation studies.
mouse embryo IFO50042 C3H/MCA clone 15 Parent strain is C3H/10T/1/2 clone 8.
mouse embryo JCRB0712 MCA-TCL16 C3H10T1/2 cl-8 derivative, methylcholanthrene-transformed, (C3H mouse) This cell line is found to be contaminated by mycoplasmas.
mouse embryo JCRB1914 MEF-N7 Mouse Embryonic Fibroblast, derived from 12.5 day old, ICR
mouse embryo IFO50019 NIH 3T3 p-7 cl-3 fibroblast (NIH Swiss mouse)
mouse embryo JCRB0615 NIH/3T3 clone 5611 A cell line which was established from NIH Swiss mouse embryo.
mouse embryo JCRB9099 SV-T2 SV40 virus-transformed BALB/3T3, (BALB/c mouse)
mouse:fibroblast          Top
mouse fibroblast JCRB0732 A9(0439)-1 contains human chromosome Xpter>Xq26::3p12>3pter (MTA with Tottori Univ. is required.)
mouse fibroblast JCRB0730 A9(2621)-4 contains human chromosome 12pter>12q24::Xq22>Xqter (MTA with Tottori Univ. is required.)
mouse fibroblast JCRB0731 A9(3552)-2 contains human chromosome 11pter>11q23::Xq26>Xqter (MTA with Tottori Univ. is required.)
mouse fibroblast JCRB0729 A9(3884)-1 contains human chromosome 16pter>16q24::Xq26>Xqter (MTA with Tottori Univ. is required.)
mouse fibroblast JCRB0728 A9(7151)-3 contains human chromosome 17pter>17q11::Xq11>Xqter (MTA with Tottori Univ. is required.)
mouse fibroblast JCRB0727 A9(An4)-2 contains human chromosome # 1 (MTA with Tottori Univ. is required.)
mouse fibroblast JCRB2210 A9(Bsr10) contains human chromosome #10 (MTA with Tottori Univ. is required.)
mouse fibroblast JCRB2223 A9(BsrX) contains human chromosome X (MTA with Tottori Univ. is required.)
mouse fibroblast JCRB2213 A9(Hygro13) contains human chromosome #13 (MTA with Tottori Univ. is required.)
mouse fibroblast JCRB2214 A9(Hygro14) contains human chromosome #14 (MTA with Tottori Univ. is required.)
mouse fibroblast JCRB2221 A9(Hygro21) contains human chromosome #21 (MTA with Tottori Univ. is required.)
mouse fibroblast JCRB2222 A9(Hygro22) contains human chromosome #22 (MTA with Tottori Univ. is required.)
mouse fibroblast JCRB2201 A9(Neo1) contains human chromosome # 1 (MTA with Tottori Univ. is required.)
mouse fibroblast JCRB2211 A9(neo11) contains human chromosome #11 (MTA with Tottori Univ. is required.)
mouse fibroblast JCRB2212 A9(Neo12) contains human chromosome #12 (MTA with Tottori Univ. is required.)
mouse fibroblast JCRB2215 A9(Neo15) contains human chromosome #15 (MTA with Tottori Univ. is required.)
mouse fibroblast JCRB2216 A9(Neo16) contains human chromosome #16 (MTA with Tottori Univ. is required.)
mouse fibroblast JCRB2217 A9(Neo17) contains human chromosome #17 (MTA with Tottori Univ. is required.)
mouse fibroblast JCRB2218 A9(Neo18) contains human chromosome #18 (MTA with Tottori Univ. is required.)
mouse fibroblast JCRB2219 A9(Neo19) contains human chromosome #19 (MTA with Tottori Univ. is required.)
mouse fibroblast JCRB2202 A9(Neo2) contains human chromosome # 2 (MTA with Tottori Univ. is required.)
mouse fibroblast JCRB2220 A9(Neo20) contains human chromosome #20 (MTA with Tottori Univ. is required.)
mouse fibroblast JCRB2203 A9(Neo3) contains human chromosome # 3 (MTA with Tottori Univ. is required.)
mouse fibroblast JCRB2204 A9(Neo4) contains human chromosome # 4 (MTA with Tottori Univ. is required.)
mouse fibroblast JCRB2205 A9(Neo5) contains human chromosome # 5 (MTA with Tottori Univ. is required.)
mouse fibroblast JCRB2206 A9(Neo6) contains human chromosome # 6 (MTA with Tottori Univ. is required.)
mouse fibroblast JCRB2207 A9(Neo7) contains human chromosome # 7 (MTA with Tottori Univ. is required.)
mouse fibroblast JCRB2208 A9(Neo8) contains human chromosome # 8 (MTA with Tottori Univ. is required.)
mouse fibroblast JCRB0726 A9(NTI8)-2 contains human chromosome # 7 (MTA with Tottori Univ. is required.)
mouse:hemo-lymphocytic          Top
mouse hemo-lymphocytic JCRB0238 B8/3 Mouse erythroleukemia cell line.
mouse hemo-lymphocytic JCRB9117 BCL1 Clone CW13.20 Mouse B cell line, where the differentiation is stimulated by B cell differentiation factors.
mouse hemo-lymphocytic JCRB9002 BW5147.G.1.4.OUA-R.1 lymphoma, T cell lymphoma, (AKR/J mouse)
mouse hemo-lymphocytic JCRB1350 EL-4 EL-4 was established from a lymphoma induced in a C57BL mouse by 9,10-dimethyl-1,2-benzanthracene.
mouse hemo-lymphocytic JCRB1352 EL-4ad A valiant cell line which adhered to a tissue culture dish was isolated from highly metastatic EL-4 murine T-lymphoma.
mouse hemo-lymphocytic IFO50111 GRSL thymic leukemia, (GR/A mouse)
mouse hemo-lymphocytic JCRB0018 J774.1 monocyte-macrophage, IL-1-producing, (BALB/c mouse)
mouse hemo-lymphocytic JCRB9026 L1210 leukemia, lymphocytic, (DBA/2 mouse)
mouse hemo-lymphocytic JCRB0709 L5178Y lymphoma, methylcholanthrene induced, (DBA/2 mouse)
mouse hemo-lymphocytic JCRB0709.1 L5178Y TK+/-3.7.2c Mouse TK+/- heterozygotic subline of the L5178Y.
mouse hemo-lymphocytic JCRB0723 L5178Y ts2 L5178Y derivative, abnormal cell division at non-permissive temperature
mouse hemo-lymphocytic JCRB0724 L5178Y ts39 A ts strain derived from L5178Y. Micronucleation observed at the non-permissive temperature (39 C).
mouse hemo-lymphocytic IFO50006 M1 Spontaneously occurred mouse myeloid leukemia, differentiate into macrophage/granulocyte.
mouse hemo-lymphocytic JCRB0110 M1-T22 Spontaneously occured myeloid leukemia cell line differentiated by dexamethasone or etc.
mouse hemo-lymphocytic IFO50008 Mm1 spontaneous myeloid leukemia, M-1-derivative, macrophage-like phenotype, (SL mouse)
mouse hemo-lymphocytic JCRB9106 MPC 11 OUAr myeloma, ourbain resistant
mouse hemo-lymphocytic JCRB0078 P-815 mastocytoma, (DBA/2 mouse)
mouse hemo-lymphocytic JCRB9109 P3.6.2.8.1 myeloma, IgG1 secreting, (BALB/c mouse)
mouse hemo-lymphocytic JCRB0009 P3/NS1/1-Ag4-1 Mouse plasmacytoma cell line resistant to 8-azaguanine.
mouse hemo-lymphocytic JCRB9107 P3/NS1/1-Ag4-1(NS-1) myeloma, plasmacytoma, non-secreting, 8-azaguanine resistant
mouse hemo-lymphocytic JCRB0017 P388 MCA induced lymphoid mouse neoplasma cell line.
mouse hemo-lymphocytic JCRB0016 P388-D1 lymphoid neoplasm, derived from P388, (DBA/2 mouse)
mouse hemo-lymphocytic IFO50036 P388D1 lymphoid neoplasm, derived from P388, (DBA/2 mouse)
mouse hemo-lymphocytic JCRB0708 P3U1 myeloma
mouse hemo-lymphocytic JCRB9030 P3X63-Ag8.653 myeloma, non-secreting, 8-azaguanine resistant, (BALB/c mouse)
mouse hemo-lymphocytic JCRB9105 P3X63Ag8 myeloma, plasmacytoma, IgG1(gamma,kappa) secreting, (BALB/c mouse)
mouse hemo-lymphocytic JCRB9085 P3X63Ag8U.1 myeloma, plasmacytoma, 8-azaguanine resistant, (BALB/c mouse)
mouse hemo-lymphocytic JCRB0113 PAI myeloma, (BALB/c mouse)
mouse hemo-lymphocytic IFO50267 PB-3c IL-3-dependent mouse bone marrow cell line.
mouse hemo-lymphocytic JCRB9084 Sp2/O-Ag14 myeloma, non-secreting, 8-azaguanine resistant
mouse hemo-lymphocytic JCRB9093 WEHI-3 leukemia, myelomonocytic, macrophage-like, (BALB/c mouse)
mouse hemo-lymphocytic IFO50296 WEHI-3b myelomonocyte, (BALB/c mouse)
mouse:hybridoma          Top
mouse hybridoma JCRB1213.1 DIG64.2B.5 Mouse hybridoma cell line producing monoclonal antibody against digoxin.
mouse hybridoma JCRB1316.5 OHP4B2.2.3 Mouse hybridoma cell line producing monoclonal antibody against 17alpha-hydroxyprogesterone.
mouse:kidney          Top
mouse kidney IFO50373 TKC2 cAMP synthesis is stimulated by arginine vasopressin in the cells. Growth temperature is 33 C.
mouse:liver          Top
mouse liver IFO50377 FLS3 This cell line supports B-cell differentiation. (Blood, 77,2612,(1991)).
mouse liver IFO50378 FLS5 Mouse liver stromal cell line.
mouse liver JCRB9075 NCTC Clone 1469 Normal cell line from mouse liver.
mouse liver IFO50080 NCTC clone 1469 The NCTC clone 1469 is a subline of NCTC 721.
mouse liver IFO50379 TLR2 P450IA1 mRNA is induced by methylcholanthrene. Growth temperature is 33 C.
mouse liver IFO50380 TLR3 P450IA1 mRNA is induced by methylcholanthrene. Growth temperature is 33 C.
mouse:lung          Top
mouse lung JCRB1349 Ex-3LL Variant cell line possessing enhanced lung metastasis ability derived from Lewis lung cancer (3LL).
mouse lung JCRB1351 Int-3LL Variant cell line possessing enhanced intravasating ability derived from Lewis lung cancer (3LL).
mouse:lung cancer          Top
mouse lung cancer JCRB1348 3LL Lewis lung carcinoma cell line.
mouse:macrophage          Top
mouse macrophage JCRB9108 J774A.1 Mouse macrophage cell line.
mouse:mammary          Top
mouse mammary JCRB0233.0 BALB-MC mammary cancer, (BALB/cHe mouse)
mouse mammary JCRB0233.1 BALB-MC.D3 mammary cancer, (BALB/cHe mouse)
mouse mammary JCRB0233.2 BALB-MC.E12 Mouse mammary tumor cell line.
mouse mammary JCRB1077 DD-762 Mouse mammary tumor cell line producing MuMTV.
mouse mammary JCRB0701 FM3A mammary carcinoma, spontaneously obtained, (C3H/He mouse)
mouse mammary JCRB0703 FM3A APRT~ mammary carcinoma, APRT-deficient FM3A, (C3H/He mouse)
mouse mammary JCRB0702 FM3A HPRT~ mammary carcinoma, HPRT-deficient FM3A , (C3H/He mouse)
mouse mammary JCRB0704 FM3A TK~ mammary carcinoma, thymidine kinase-deficient FM3A, (C3H/He mouse)
mouse mammary JCRB9077 MMT 060562 spontaneous mammary tumor
mouse mammary JCRB1413 ST 13 Mouse normal preadipocyte cell line established from ddN mouse. ST 13 can be induced to differentiate into fat-accumulating cells in vitro.
mouse mammary JCRB0705 ts85 FM3A derivative, defective in ubiquitin activating enzyme, (C3H mouse)
mouse mammary JCRB0706 tsFT101 FM3A derivative, cytokinesis is blocked at 39 C, (C3H mouse)
mouse:melanoma          Top
mouse melanoma JCRB0202 B16 melanoma Mouse skin melanoma cell line.
mouse:neural          Top
mouse neural IFO50519 A1 derives from p53-deficient mouse brain, used for preparation of conditioned medium for MG5 cells
mouse neural IFO50424 AP-16 Astrocyte differentiation is induced by TGF-beta, LIF, CNTF and serum The deprivation of EGF induces death of AP-16 cells by apoptosis.
mouse neural JCRB1571 F6B3 Mouse cell line derived from mouse brain tumor.
mouse neural IFO50161 KT-5 GFAP and S-100-positive, MBP, thy-1 and neurofilament-negative. (Tested at the IFO.).
mouse neural IFO50293 MA-89 Not immortalized cells. Limited life span.
mouse neural JCRB0145 MEB 5 Multipotent CNS stem cell line of mouse. Cells differentiate into neuron, astrocytes and oligodendrocytes.
mouse neural IFO50472 MEB5 Neural stem cell line established from embryonic 14.5 day mouse cerebrum by E7 oncogene of HPV type 16. Withdrawal of EGF induces apoptosis or differentiation to neurons, astrocytes, and oligodendrocytes. LIF induces differentiation into astrocytes.
mouse neural IFO50520 MG5 A microglial cell line from p53-deficient mice. Requires conditioned medium of A1 cell line (or of astrocytes) for cultivation of MG5 cells.
mouse neural IFO50081 Neuro-2a Derivative of C1300 tumor. C1300 tumor was originally described as a spontaneous tumor of the region of spinal cord. Later studies suggested that it is drived from sympathetic cells in peripheral nervous system.
mouse neural IFO50495 Neuro-2aTG This cell line is HPRT-deficient clone from EMS-mutagnenized Neuro-2a cells. HAT-sensitive, 6-thioguanine-registant.
mouse neural JCRB1574 RSV-M Mouse cell line derived from mouse brain tumor.
mouse neural JCRB1580 SR-CDF1 DBT Mouse cell line derived from mouse brain tumor.
mouse neural JCRB1361 Vn1919 neuroglial and neuronal character coexpressing ependymoma cell line.
mouse neural JCRB1365 Vn1919 cl4 neuroglial and neuronal character coexpressing ependymoma cell line.
mouse neural JCRB1367 Vn1919 cl49 neuroglial and neuronal character coexpressing ependymoma cell line.
mouse neural JCRB1368 Vn1919 cl59 neuroglial and neuronal character coexpressing ependymoma cell line.
mouse:olfactory epithelium          Top
mouse olfactory epithelium IFO50484 DBC1.2 This cell line is likely to be derived from olfactory dark (horizontal) basal cell. Keratin is expressed in this cell line.
mouse:ovary          Top
mouse ovary JCRB1026 OV3121 A non-metastatic epitherial tumor cell line established from ovarian granulosa cell tumor irradiated with 60-Co-gamma rays. Cells are producing estradiol continuously.
mouse ovary JCRB0186 OV3121ras4 Mouse ovarian granulosa cell tumor line with v-Ha-ras gene.
mouse ovary JCRB0187 OV3121ras7 Mouse ovarian granulosa cell tumor line with v-Ha-ras gene.
mouse ovary JCRB0151.1 p53-def-MOSE ovarian surface epithelial cell line from p53(-/-) mouse
mouse ovary JCRB0151 T-Ag-MOSE Cells are derived from normal ovary of adult C3H/He mouse and immortalized by the plasmid pEF321-T containing T antigen gene. Cells are tumorigenic in nude mice.
mouse:pituitary          Top
mouse pituitary JCRB9098 AtT-20 pituitary tumor, ACTH producing, (LAF1 mouse)
mouse:sarcoma          Top
mouse sarcoma JCRB9089 CCRF S-180 II S-180 sarcoma derivative
mouse sarcoma IFO50268 EHS This cell line secretes basement membrane matrix including laminin and type IV collagen.
mouse:skin          Top
mouse skin JCRB0211 A9 skin fibroblast, 8-azaguanine-resistant, (C3H mouse)
mouse skin JCRB0212 B82 skin fibroblast, bromodeoxyuridine-resistant
mouse skin JCRB1198.01 GP8 The mouse SV cell line rescued with a human normal behta-galactosidase gene.
mouse skin JCRB1225 I51T Mouse behta-galactosidase deficient cell line introduced human defcient bethta-galactosidase gene.
mouse skin JCRB0125 L alpha L cell line introduced with poliovirus receptor protein alpha gene, thymidine kinase defective
mouse skin JCRB0722 L cl 1D fibroblast, thymidine kinase-deficient, (C3H mouse)
mouse skin JCRB0648 L.P3 Serum free cell line of the mouse L929 cell line.
mouse skin JCRB0605 L.P3(S) L cell derived, can grow in a serum-free medium, (C3H mouse)
mouse skin JCRB1322 m5S Near-diproid mouse embryonic cell line.
mouse skin JCRB9003 NCTC Clone 929 fibroblast, subclone of strain L, (C3H/An mouse)
mouse skin IFO50409 NCTC clone 929 A clone of L cells, and often referred as L929. The L cells was established from normal subcutaneous areolar and adipose tissue.
mouse skin JCRB1207 SV SV40 immortalized beta-galactosidase gene deficient mouse fibroblast cell line. Human disease animal model mouse (GM1 gangliosidosis) derived cell line.
mouse:spleen          Top
mouse spleen IFO50375 MSS31 spleen stromal cell line, (C57BL/6 mouse)
mouse spleen IFO50376 MSS62 spleen stromal cell line, (C57BL/6 mouse)
mouse:teratoma          Top
mouse teratoma JCRB0721 F9 teratocarcinoma, differentiation-inducible, (129/Sv mouse)
mouse teratoma JCRB0001 F9-41 Mouse testicular teratocarcinoma cell line.
mouse teratoma JCRB0720 OTT6050 teratocarcinoma, (129/Sv mouse)
mouse teratoma JCRB0206 PCC4 AG teratocarcinoma, 8-azaguanine-resistant, (129/Sv mouse)
mouse teratoma JCRB0216 PCC4 AG Cap teratocarcinoma, 8-azaguanine, chloramphenicol-resistant (129/sv mouse)
mouse:testis          Top
mouse testis JCRB0243 B-1 Leydig cell tumor, estrogen-dependent, (BALB/c mouse)
mouse testis JCRB9097 I-10 Leydig cell testicular tumor (BALB/cJ mouse)
mouse:thymidylate defective          Top
mouse thymidylate defective JCRB0719 FSthy21 complete defective strain of thymidylate synthase, (C3H mouse)
mouse:thymus          Top
mouse thymus IFO50248 IT-79MTNC3 thymic nurse cell, (BALB/c mouse)
mouse:vascular system          Top
mouse vascular system JCRB0150 P53LMACO1 Smooth muscle cell line established from thoracic aorta of a p53 knock out mouse.
mouse vascular system IFO50374 TKD2 Acetylated low-densitiy lipoprotein is incorporated into the cells. Temperature sensitive cell line. Growth temperature is 33 C.
mouse x human:antibody-producing hybridoma          Top
mouse x human antibody-producing hybridoma IFO50090 4G12 hybridoma This cell line produces human monoclonal 4G12 antibody (Ig lambda). The 4G12 antibody recognizes a glycoprotein with Mr = 65,000. Immunohistochemically, 4G12 reacts especially with lung carcinomas and with some malignant tumors.
mouse x rat:antibody-producing hybridoma          Top
mouse x rat antibody-producing hybridoma JCRB9092 7D4 anti-murine IL-2 receptors (rat antibody)
mouse x rat antibody-producing hybridoma JCRB1385 CAS-9 Hybridoma cell line producing antibody against mouse CD49d (VLA-4 a chain). Binding inhibition VLA-4/Fibronectin.
mouse x rat antibody-producing hybridoma JCRB1370 TAS-5 Hybridoma cell line producing antibody against mouse CD49d (VLA-4 a chain). Binding inhibition VLA-4/VCAM-1 and VLA-4/Fibronectin
mouse x rat antibody-producing hybridoma JCRB1353 TER-119 Hybridoma cell line producing antibody against mouse erythrocyte membrane antigen Ly76.
mouse x rat:cybrid          Top
mouse x rat cybrid JCRB0203 PCC4 TypeIII PCC4 fused with cytoplasts of rat myoblastic cell (L6TG Cap-r)
mouse x rat:neural          Top
mouse x rat neural IFO50221 N18-RE-105 Neuron like cells established from mouse N18TG2 x Fischer rat 18 day-embryonic neural retina.
pig:kidney          Top
Japan Domestic use only pig kidney JCRB0060 LLC-PK1 susceptible to rubella, vaccinia and herpes viruses
Japan Domestic use only pig kidney JCRB9040 PK(15) kidney
Japan Domestic use only pig kidney IFO50422 PKF The name PKF derives from Pig Kidney Fibroblastic.
Japan Domestic use only pig kidney IFO50423 PKR The name PKR derives from Pig Kidney Rough (outline of cell morphology).
Japan Domestic use only pig kidney IFO50421 PKS The name PKS derives from Pig Kidney Smooth (outline of cell morphology).
pygmy mouse:tail          Top
pygmy mouse tail JCRB9124 M.dunni(Clone III8C) normal, support the growth of all 4 classes of MuLV
rabbit:cornea          Top
rabbit cornea JCRB0246 RC-1 cornea, (white rabbit)
rabbit cornea JCRB9122 SIRC susceptible to rubella virus
rabbit cornea IFO50020 SIRC susceptible to rubella virus
rabbit:kidney          Top
rabbit kidney JCRB9034 LLC-RK1 an aneuploid cell line, (New Zealand white rabbit)
rabbit:lung          Top
rabbit lung JCRB0131 RL-33 Japansese white rabbit lung cell line sensitive to HSV or VSV.
rat:colon          Top
rat colon JCRB0167 RCN-9 DMH induced colonic cancer, (F344/DuCrj rat)
rat:embryo          Top
rat embryo JCRB0734 3Y1-B Clone 1-6 fibroblast, whole embryo, (Fischer 344 rat)
rat embryo IFO50277 5RP7 fibroblast transformed by c-Ha-ras oncogene
rat embryo JCRB0737 Ad12-3Y1-Z19 3Y1 derivative, Ad12-transformed, (Fischer rat)
rat embryo JCRB0738 E1A-3Y1-1 3Y1 derivative, transformed by E1A of Ad12 virus, (Fischer rat)
rat embryo IFO50015 F2408 Rat fibroblast cell line.
rat embryo JCRB0143.5 F2408 EBNA2 cl-14 EBNA2-transfected, (Fischer rat)
rat embryo JCRB0143.2 F2408 EBNA2 cl-16 F2408 cell line transfected with recombinant plasmid pZE2 with coding region of the EBNA2 and the expression of the EBNA2 was strong in this strain.
rat embryo JCRB0143.3 F2408 EBNA2 cl-18 Rat embryo cell line transfected by recombinant plasmid pZE2 with coding region of the EBNA2.
rat embryo JCRB0143.6 F2408 EBNA2 cl-23 This cell line is one of a series of F2408 rat cell lines with recombinant plasmid pZE2 with coding region of the EBNA2 transfected, but the expression of the EBNA2 was weak in this strain.
rat embryo JCRB0143.4 F2408 EBNA2 cl-24 EBNA2-transfected, (Fischer rat)
rat embryo JCRB0143.7 F2408 EBNA2 cl-28 F2408 cell line transfected with recombinant plasmid pZE2 having coding region of the EBNA2 but the expression of the EBNA2 was weak.
rat embryo JCRB0143.1 F2408 EBNA2 cl-9 EBNA2-transfected, (Fischer rat)
rat embryo JCRB0143.0 F2408 pZipNeo F2408 cell line transfected with pZipNeo plasmid alone as a control against pZE2 transfected F2408 cell line series.
rat embryo IFO50099 F2408-B812 HGPRT-deficient line from F2408 (IFO 50015). This cell line exhibits temperature sensitive phenotype for transformation by Moloney MSV.
rat embryo IFO50100 F2408-B993 HGPRT-deficient line from F2408 (IFO 50015). This cell line exhibits temperature sensitive phenotype for transformation by Moloney MSV.
rat embryo IFO50101 F2408-No.20 Thymidine kinase-deficient line from F2408 (IFO 50015).
rat embryo IFO50098 F2408-No.3 HGPRT-deficient line from F2408 (IFO 50015).
rat embryo IFO50102 F2408-No.7 HGPRT-deficient line from F2408 (IFO 50015).
rat embryo JCRB0743 HR-3Y1-2 3Y1 derivative, transformed by v-H-ras cDNA, (Fischer rat)
rat embryo JCRB0739 NG-3Y1-T15L 3Y1 derivative, transformed by MNNG, (Fischer rat)
rat embryo JCRB0740 NG-3Y1-T308 3Y1 derivative, transformed by MNNG, (Fischer rat)
rat embryo JCRB0741 NG-3Y1-T6R 3Y1 derivative, transformed by MNNG, (Fischer rat)
rat embryo JCRB0736 Py-3Y1-S2 3Y1 derivative, mouse polyoma virus-transformed, (Fischer rat)
rat embryo IFO50282 RAT-2 thymidine kinase deficient RAT-1 (F2408) cell line, (Fischer rat)
rat embryo JCRB0742 SR-3Y1-2 3Y1 derivative, transformed by Rous sarcoma virus, (Fischer rat)
rat embryo JCRB0735 SV-3Y1-C66 3Y1 derivative, SV40-transformed, (Fischer rat)
rat embryo JCRB0153.2 tsJT16 Rat 3Y1 derived ts mutant cell line for cell cycle progression from G0 and G1 to S phase.
rat embryo JCRB0153.3 tsJT60 Rat 3Y1 derived ts mutant cell line with cell cycle arrest at G0 phase.
rat embryo JCRB0153.1 tsJT663 Rat embryo cell line with ts mutation for cell cycle progression from G1 to S phase.
rat:hemo-lymphocytic          Top
rat hemo-lymphocytic JCRB0168 c-WRT-7-LR A transplantable rat myelomonocytic leukemia cell line induced in a WKA rat by neonatal injections of RLV (Rauscher leukemia virus).
rat hemo-lymphocytic IFO50034 RBL-1 leukemia, basophilic (Wistar rat)
rat hemo-lymphocytic JCRB0241 Shay granurocytic sarcoma, (Wister rat)
rat hemo-lymphocytic JCRB9091 Y3-Ag 1.2.3 myeloma, kappa secreting, 8-azaguanine resistant, (Lou rat)
rat:kidney          Top
rat kidney IFO50280 77N1 Parental strain is NRK (normal rat kidney) cells (J. Bacteriol.,92, 1133 (1966)).
rat kidney JCRB1585 ACI-RCC Rat chemically induced renal cell carcinoma cell line. (induced by ferric nitrilotriacetate (Fe-NTA))
rat kidney JCRB9067 NRK-49F fibroblastic clone of NRK (normal rat kidney) cells, useful for transformation assays, (Osbone-Mendel rat)
rat kidney IFO50481 NRK-49F NRK-49F is a fibroblastic clone of NRK (mixed culture of normal rat kidney) cells. (J. Bacteriol., 92, 1133 (1966)). This cell line exhibits contact inhibition and is useful for transformation assays.
rat kidney IFO50480 NRK-52E NRK-52E is a epithelioid clone of NRK (mixed culture of normal rat kidney) cells. (J. Bacteriol., 92, 1133 (1966)).
rat:leukemia          Top
rat leukemia JCRB0023 RBL-2H3 Famous rat mast cell line releasing IgE mediated histamine, established from peripheral blood with basophilic leukemia.
rat:liver          Top
rat liver JCRB0431 3'-mRLh-2 hepatoma, (Donryu rat)
rat liver JCRB0421 3'-mRLN-30 liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
rat liver JCRB0422 3'-mRLN-31 liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
rat liver JCRB0408 Ac2F normal liver, diploid, (Donryu rat)
rat liver JCRB0416 Ac2F(DT) Ac2F-derived, 3'-methyl-4-dimethylaminoazobenzene transformed, (Donryu rat)
rat liver JCRB0417 Ac2F(ST) Ac2F-derived, spontaneously transformed, (Donryu rat)
rat liver JCRB0714.1 AH-7974.P3 Serum free rat ascited hepatoma cell line. Cells have been maintained by passage for long time. Extremely high passage number.
rat liver JCRB0132.1 AH601(JTC27) A transplantable rat hepatoma cell line derived from ascites.
rat liver JCRB0132.2 AH601.P3(JTC27) AH-601 cell line adapted to a serum free medium.
rat liver JCRB0132.3 AH601.P3(JTC27) AH-601 cell line adupted to a serum free medium with long passage history.
rat liver JCRB0411 AH66tc ascites hepatoma, (Donryu rat)
rat liver JCRB0412 AH70Btc ascites hepatoma, (Donryu rat)
rat liver JCRB0248 ARLJ301-3 liver epithelial cell, (F344/DuCrj rat)
rat liver JCRB0025 BRL-3A MSA (somatomedin-like) protein producing, (Buffalo rat)
rat liver JCRB9114 BRL-3A MSA (somatomedin-like) protein producing, (Buffalo rat)
rat liver JCRB0409 dRLa-74 Clone 2 liver adenoma, (Donryu rat)
rat liver JCRB0410 dRLh-84 hepatoma, (Donryu rat)
rat liver JCRB0418 dRLN-4 liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
rat liver JCRB0420 dRLN-6 liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
rat liver JCRB0419 dRLN-9 liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
rat liver JCRB0249 FAA-HTC1 hepatocellular carcinoma, 2-acetylaminofluorene induced, (F344/DuCrj rat)
rat liver JCRB1040 FF101 Rat hepatoma cell line with producing unidentified growth factor maintained in serum-free RPMI1640 medium for 444 passages.
rat liver JCRB0610 IAR-20 non-transformed live cell line, (BD-IV rat)
rat liver JCRB0714 JTC-16 P3 Serum free rat ascites hepatoma cell line.
rat liver JCRB0152.1 M Cell line which is derived from RLC-3 (JAR rat) after 54 day-culture by Nagisa method with treatment of DAB(10ug/ml) for one week. Cells are capable to form collagen network.
rat liver JCRB0152.2 M.P3 M cells derived from RLC-3 (JAR rat) was habituated to serum free culture medium.
rat liver JCRB0152.3 M.P3 M cells derived from RLC-3 (JAR rat) was habituated to serum free culture medium.
rat liver JCRB1088 RI-T Rat hepatic stellate cell(HSC) line immortalized with SV40 T antigen.
rat liver JCRB0247 RL-34 normal, collagen-induced growth arrest, (Wistar rat)
rat liver JCRB0718 RLC-10.P3 Serum free cell culture derived from rat liver.
rat liver JCRB0718.1 RLC-10.P3 Rat normal cell line cultured with serum free medium for long passages.
rat liver JCRB0415 RLN-10 normal liver, (Donryu rat)
rat liver JCRB0414 RLN-8 normal liver, (Donryu rat)
rat liver JCRB0402 RLN-B2 normal liver, (Donryu rat)
rat liver JCRB0407 RLN-J-5-2 normal liver, (Donryu rat)
rat liver JCRB0193 WB-F344 Normal liver epitherial cell line from rat, Fischer-344.
rat:lung          Top
rat lung JCRB0229 EGV-4T immortal cell line from MNNG-transformed tracheal epithelial cells
rat lung JCRB0608 JTC19 lung, (JAR-1 rat)
rat lung JCRB9053 L-2 adult lung
rat:lymph node          Top
rat lymph node JCRB0144.1 LYM-1.P3 The cells are cultured under serum free condition that are derived from lymph node. Cells are sticky to culture dishes.
rat lymph node JCRB0144.1B LYM-1.P3B Serum free FAR-2.F60 rat cell culture from lymph node near colon cancer.
rat lymph node JCRB0144.1D LYM-1.P3D Serum free FAR-2.F60 rat cell culture from lymph node near colon cancer.
rat:mammary          Top
rat mammary JCRB0242 RMT-1 E4 DMBA induced rat mammary carcinoma cell line.
rat mammary JCRB0245 RMT-1 M2 Rat mammary carcinoma cell line from rat mammary gland induced by single shot DMBA(20mg) administrated by oral.
rat:muscular system          Top
rat muscular system JCRB9081 L6 skeletal muscle myoblast
rat muscular system IFO50364 L6 skeletal muscle myoblast
rat muscular system JCRB0209 L6TG skeletal muscle myoblast, 6-thioguanine-resistant
rat muscular system JCRB0210 L6TG Cap skeletal muscle myoblast, 6-thioguanine, chloramphencol-resistant
rat:neural          Top
rat neural JCRB9096 C6 glial tumor, GFAP-positive
rat neural IFO50110 C6 glial tumor, GFAP-positive
rat neural IFO50425 C6-SF2 C6 subline adapted to serum-free medium
rat neural IFO50490 MDM2-RNB human MDM2 protein-expressing astrocyte cell line, (Wistar rat)
rat neural JCRB0733 PC-12 pheochromocytoma, , neuronal differentiation by NGF, adhesive variant
rat neural IFO50278 PC-12 pheochromocytoma, neuronal differentiation by NGF, grow in suspension
rat neural JCRB0130 PC-12.P3 Rat pheochromo cytoma cell line derived from adrenal medulla. Use serum free DM201 media.
rat neural IFO50496 PC-12TG HAT-sensitive, 6-thioguanine-resistant.
rat neural JCRB0130.1 PC12.P3 PC-12 derivative adapted to serum-free culture, direct deposition by original developer.
rat neural JCRB0266 PC12HS Highly NGF sensitive clone of rat PC12 cell line.
rat neural JCRB0263.1 PC12HS.P3 Serum free NGF sensitive PC12HS cell line.
rat neural JCRB0268 PC12IS NGF insensitive clone of rat PC12 cell line.
rat neural JCRB0267 PC12MS Moderately NGF sensitive clone of rat PC12 cell line.
rat neural JCRB0129.1 RCR-1 Rat astrocyte-like cells producing GFAP. Serum free cell line (RCR-1.P3) is also available.
rat neural JCRB0129.0 RCR-1.P3 Rat astrocyte-like cell line prducing GFAP in serum free cell culture. Parental strain of this cell line is also available(JCRB0129.1).
rat neural IFO50491 RNB RNB cells are the parent cells of MDM2-RNB cells (IFO 50490).
rat:pituitary          Top
rat pituitary JCRB9046 GH1 pituitary tumor, somatotrophin-secreting, (Wistar/Furth rat)
rat pituitary IFO50269 GH1 pituitary tumor, somatotrophin-secreting, (Wistar/Furth rat)
rat pituitary JCRB9047 GH3 pituitary tumor, somatotrophin and prolactin-secreting, (Wistar/Furth rat)
rat pituitary IFO50105 GH3 Rat pituitary tumor secreting somatotrophin.
rat:sarcoma          Top
rat sarcoma JCRB1001.1 MS-653-A Highly metastatic rat fibrosarcoma cell line induced by methylcholanthrene.
rat sarcoma JCRB1001.2 MS-653-G Rat fibrosarcoma cell line induced by methylcholanthrene.
rat sarcoma JCRB0259 MSK osteosarcoma, 32P-induced, (F344 rat)
rat sarcoma IFO50017 XC RSV-induced sarcoma, useful for assay of murine leukemia virus, (Wistar rat)
rat:skin          Top
rat skin JCRB0005 FRSK Fetal rat skin keratinocyte cell line.
rat:spleen          Top
rat spleen JCRB0423 RS-A spleen, spontaneously transformed cells, (Donryu rat)
rat:squamous cell carcinoma          Top
rat squamous cell carcinoma JCRB0230 SCC-131 Rat squamous cell carcinoma cell line.
rat squamous cell carcinoma JCRB0231 SCC-158 squamous cell carcinoma
rat:submandibular gland          Top
rat submandibular gland JCRB1146 RSMG-1 Stem cell like cell line from female rat submandibular gland.
rat:testis          Top
rat testis JCRB9064 LC540 Leydig cell testicular tumor
rat testis JCRB9055 R2C Leydig cell testicular tumor,steroid secreting
rat:thymus          Top
rat thymus IFO50078 IT-26R21 T cell differentiation factor producing, (Wistar rat)
rat thymus IFO50076 IT-45R1 T cell differentiation factor producing, (Wistar rat)
rat thymus IFO50077 IT-45R91 thymic fibroblast, (Wistar rat)
rat thymus IFO50112 TaD-1 thymoma, keratin-positive, (ACI x BUF/Mna, F1 rat)
rat thymus IFO50120 TaD-1-3 This cell line is a clone of TaD-1 cells (IFO 50112).
rat thymus IFO50103 TuD-1 thymic stroma, keratin-positive, (ACI rat)
rat thymus IFO50152 TuD-1-3 This cell line is a clone of TuD-1 cells (IFO 50103).
rat:thyroid          Top
rat thyroid IFO50270 6-23 clone 6 medullary thyroid carcinoma, neurotensin and calcitonin-producing, (WAG/RIJ rat)
tupaia:lung          Top
Japan Domestic use only tupaia lung JCRB0745 T-23 clone 8 normal, applicable for the mutation assay system in vitro